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ABSTRACT
Epithelia provide a protective barrier for the organs they encase, yet the 
cells compromising the epithelia constantly turn over via cell death and cell 
division. Our lab has identified a process by which cells are removed from an 
epithelial layer without compromising its barrier function called ‘epithelial cell 
extrusion’. To extrude, a cell emits the bioactive lipid Sphingosine 1 Phosphate 
(S1P), which binds the S1P2 receptor in the neighboring cells and triggers them 
to form an actomyosin ring that contracts to squeeze the cell out of the epithelial 
layer. Although extrusion removes apoptotic cells in response to damage, typically 
during homeostasis, epithelia extrude live cells that later die by anoikis. Wild 
type cells extrude predominantly apically and are eliminated through the lumen; 
however, we found that some cells extrude basally, back into the tissue the 
epithelium encases. Because most cells extrude while alive and many aggressive 
tumors override anoikis signaling to enhance survival outside the epithelium, the 
direction a cell extrudes has important consequences to its later fate.  Transformed 
cells that extrude apically would be eliminated through the lumen; however, those 
extruding basally could potentially invade into the stroma. My goal was to elucidate 
the mechanisms that control the direction a cell extrudes from epithelia. My first 
study showed that apical extrusion requires microtubules and that they target p115 
RhoGEF in the cells surrounding an extruding cell to the basolateral surface of 
the live/extruded cell interface to activate Rho-mediated actin/myosin contraction 
basolaterally. Blocking this mechanism by microtubule disrupters causes cells to 
instead contract apically and extrude basally. In my second study, I found that cells 
iv
expressing oncogenic K-Ras shift extrusion basally and enable extruded cells to 
survive and proliferate. In this situation, basal extrusion results from degradation 
of S1P due to autophagy that is highly upregulated in oncogenic K-Ras cells. 
Although S1P2 also becomes slightly downregulated in K-Ras expressing cells 
too, disruption of the autophagy flux is sufficient to rescue both S1P levels and 
apical extrusion. Similarly, several aggressive tumors that are driven by K-Ras 
mutations lack S1P2. S1P2 deficient epithelia are extrusion deficient, which results 
in neoplastic masses that are chemoresistant, basal extrusion, and poor barrier 
function both in vitro and in vivo, all properties that could contribute to tumor 
formation and progression.  Currently, I am developing an in vivo model system 
in zebrafish epidermis to investigate if basal cell extrusion can drive invasion of 
oncogenic K-Ras cells. The transparency of zebrafish allows us for the first time to 
directly follow extrusion, invasion, and migration of individual cells without invasive 
techniques intrinsic to most current cancer models.
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12    CHAPTER 1
INTRODUCTION: TUMOUR CELL INVASION: AN EMERGING ROLE FOR 
BASAL EPITHELIAL CELL EXTRUSION
Reprinted with permission from Nature Reviews Cancer. Gloria M. 
Slattum and Jody Rosenblatt (2014). Tumour cell invasion: an emerging 
role for basal epithelial cell extrusion. Nat. Rev. Can. 14 (7): 495-501.
Chapter 1 is a published article. 
2A crucial primary step for cancer metastasis 
is invasion, but we know very little about the 
mechanisms that govern it. As metastasis 
is the main reason that patients succumb 
to cancer, understanding the mechanisms 
that initiate metastasis will be crucial for 
targeting aggressive tumours. Because it 
has been difficult to directly follow tumour 
cell invasion from the epithelia, where most 
human cancers arise, we do not yet have a 
clear picture of the mechanisms that drive 
this process. In considering how tumour 
cells invade, it is helpful to understand 
how normal epithelia function and behave. 
Epithelia form a selective and protective 
barrier for all of the tissues that they encase. 
The polarized epithelium contains an apical 
surface that faces the lumen (external envi‑
ronment) and a basal surface that faces the 
basement membrane. Epithelia are the first 
line of defence against pathogens and toxins 
and, therefore, the cells that constitute epi‑
thelia are exposed to potential damage. As a 
result, many epithelia constantly turn over 
by cell division and death. We found that to 
maintain homeostatic epithelial cell num‑
bers, when epithelia become too crowded 
owing to cell division elsewhere in the 
layer, some cells extrude and later die1. By 
extruding, cells that are destined for death 
are seamlessly ejected from the monolayer 
by concerted contraction of the cells that 
surround them2. Typically, because these 
cells extrude apically, they detach from 
the matrix and its associated survival sig‑
nals, and die by anoikis. However, because 
metastatic tumour cells can, in some cases, 
override anoikis by upregulating survival 
signalling3,4, we propose that extrusion 
could enable them to escape the epithelium. 
Normally, epithelia extrude cells apically 
into the lumen, which would function to 
remove any transformed cells, thereby 
essentially suppressing tumorigenesis. 
Intriguingly, we have found that oncogenic 
signalling can alter normal apical extrusion 
and cause cells to instead extrude basally 
under the epithelium. In this way, basal 
extrusion could enable transformed cells 
that are refractory to cell death to invade the 
underlying stroma. In this Opinion article, 
we discuss how misregulation of extrusion 
and normal epithelial survival mechanisms 
could enable tumours to initiate metastasis 
by subverting a process that normally  
triggers epithelial cell death.
Mechanisms of epithelial cell extrusion
Dying cells could pose a threat to the tight 
barrier that epithelia form, but they do not. 
Instead, epithelial cells that are destined to 
die are extruded by contraction of an actin 
and myosin ring in the surrounding cells, 
which squeeze cells out of the epithelium 
while closing the potential gap that could 
have formed from the exit of the cells 
(FIG. 1). All of the epithelia that have been 
observed, across animals from Drosophila 
melanogaster, zebrafish, mice and humans, 
extrude epithelial cells through what seems 
to be a highly conserved mechanism1,2,5–8. 
For a cell to extrude, it produces and 
secretes the bioactive lipid sphingosine‑ 
1‑phosphate (S1P), which then binds 
to S1P receptor 2 (S1P2; also known 
as S1PR2; a G protein‑coupled recep‑
tor) in the surrounding cells9 to contract 
an intercellular actomyosin band that 
squeezes the cell out of the epithelium2. 
Additionally, we and others have observed 
that the cell being extruded also contracts, 
thereby aiding in its removal10. Epithelia 
extrude either live cells during homeosta‑
sis or dying cells in response to apoptotic 
stimuli1,2,6,11. We have found that epithelia 
maintain cell number homeostasis by 
extruding live cells once cells at a given 
site become up to 1.6‑fold to 1.8‑fold more 
crowded1. Crowding‑induced extrusion 
occurs through activation of the mecha‑
nosensitive ion channel, PIEZO1, which 
presumably triggers calcium currents12 to 
activate S1P‑dependent extrusion of live 
cells, which later die by anoikis. Apoptotic 
stimuli, such as chemotherapies, toxins 
or pathogens that trigger cell death can 
also activate cell extrusion through the 
S1P–S1P2 pathway9, possibly in response 
to caspase activation11. Thus, both during 
natural cell turnover and following the 
induction of apoptosis, the S1P–S1P2 path‑
way activates cells to extrude in a manner 
that ensures no gaps form in the epithelia 
as cells are expelled.
Apical versus basal extrusion
Normally, epithelia extrude cells apically 
into the lumen, but in some situations, 
cells can also extrude basally into the 
underlying tissue. The direction in which 
a cell extrudes depends on where the acto‑
myosin band contracts in neighbouring 
cells13. To extrude a cell apically, contrac‑
tion occurs towards the base of the cell, 
whereas to extrude it basally, contraction 
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occurs at the apex (FIG. 1). The direction 
in which a cell extrudes can have impor‑
tant consequences for the fate of the cell, 
especially when live, transformed cells 
are extruded. Apical extrusion eliminates 
cells with upregulated survival signalling 
through the lumen (FIG. 1). For example, 
in the intestine, apical extrusion would 
remove putative tumour cells into the 
waste canal. Similarly, transient mosaic 
expression of oncogenic HRASV12 or v‑src 
transforms cells and causes them to self‑
segregate away from the wild‑type epi‑
thelium in a process that is similar to but 
different from extrusion, which essentially 
removes them14,15. In mammary or prostate 
glands, apical extrusion could lead to car‑
cinoma in situ — a tumour type with good 
prognosis in which cells accumulate in 
the luminal space and are generally non‑
invasive16,17. However, basal extrusion  
preserves live cells within the organ (FIG. 1). 
During development, basal extrusion 
could enable cells to dedifferentiate from 
the epithelium and then differentiate 
into new cell types, as during neuroblast 
delamination in D. melanogaster 18. For 
tumours, basal extrusion could enable 
transformed cells to invade the tissue that 
the epithelium encases to initiate metas‑
tasis. Intriguingly, oncogenic mutations 
can subvert the normal extrusion pathway, 
shifting the direction of extrusion from 
apical to basal, and this suggests a link 
between basal extrusion and invasiveness. 
A basally extruded cell could either divide 
and accumulate beneath the epithelium or 
invade, depending on its ability to cross 
the basement membrane by either degrad‑
ing or invading the underlying matrix19. 
Many tumours express various matrix 
metallo proteinases, which suggests that 
matrix degradation may be intrinsic to 
transformation, enabling basally extruded 
transformed cells to transit through the 
basement membrane. However, in vivo 
studies have suggested that cancer cells 
can breach the basement membrane 
without degrading it, by extending inva‑
dopodia that squeeze through gaps in the 
matrix and push it apart20,21. Determining 
whether basally extruded cells can breach 
the basement membrane and how they 
do so will be important goals for future 
in vivo studies.
Apical extrusion seems to require at 
least two activities: S1P–S1P2 signalling 
and microtubule dynamics. Microtubules 
reorient to the basolateral interfaces of 
both the extruding and neighbouring 
cells to localize RHO guanine nucleotide 
exchange factor 1 (ARHGEF1; also known 
as p115RHOGEF) and thereby activate 
RHO‑mediated actomyosin contraction 
under the extruding cell, driving it out 
apically13 (FIG. 2a). Disruption of micro‑
tubule dynamics shifts extrusion basally13. 
Although microtubules reorient in both 
the extruding cell and its neighbours, 
cell‑autonomous knockdown of a crucial 
microtubule regulator, adenomatous poly‑
posis coli (APC), suggests that the direction 
in which a cell extrudes requires dynamic 
microtubules only within the extruding 
cell22. Because the S1P–S1P2–RHO pathway 
controls only apical but not basal extru‑
sion23, one possibility is that, in the extrud‑
ing cell, microtubules target S1P to restrict 
contraction and membrane recycling baso‑
laterally, where it is needed to drive apical 
extrusion (FIG. 2a). When any machinery 
that controls apical extrusion is aberrant, 
cell‑autonomous contraction of cortical 
actin and myosin at existing apical junc‑
tions could enable a cell to extrude basally. 
Recent studies show that cell‑autonomous 
apical contraction precedes the baso lateral 
contraction in the neighbouring cells, 
and this suggests that loss of basolateral 
contraction would naturally lead to basal 
extrusion10. However, how complete apical 
contraction is controlled is still unknown, 
as are other signals and mechanisms 
that might collaborate to control apical 
extrusion.
Diverting extrusion basally
Oncogenic signalling. Although there 
is no direct proof that basal extrusion 
drives tumour cell invasion, we have 
found that oncogenic mutations can 
manipulate apical extrusion, a process 
that normally promotes cell death, into 
a process that could allow cells to escape 
into the stroma. Mutations that disrupt the 
Figure 1 | The direction in which a cell extrudes has important consequences for its fate. 
Extrusion removes either live or dying epithelial cells in response to crowding during homeostasis or 
apoptotic stimuli, respectively. Typically, live cells extrude apically from the epithelium into the lumen 
by contracting an intercellular actomyosin band basolaterally to squeeze the cell out (left). Apically 
extruded cells generally die in the lumen by the loss of survival signals from the matrix — a process 
called anoikis (top). Tumour cells with upregulated survival signalling could still be eliminated through 
the lumen by apical extrusion, which could function like a tumour-suppressor mechanism (top). Less 
frequently, cells extrude basally by apical contraction (right), back into the tissue that the epithelium 
encases. Several oncogenic mutations disrupt apical extrusion, thereby driving cells to extrude basally 
instead. Because basally extruded cells with upregulated survival signals can bypass anoikis, this may 
provide a novel mechanism to enable oncogenic cells with upregulated survival signalling to initiate 
invasion (bottom).
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a  Wild type: apical extrusion b  APC mutant: basal extrusion c  KRAS or S1P mutant: 
      basal extrusion (no S1P or S1P2)
S1P2
tumour‑suppressive function of APC or 
constitutively activate KRAS disrupt nor‑
mal apical extrusion by disrupting either 
cytoskeletal dynamics or S1P signalling, 
respectively (FIG. 2b,c). APC is mutated or 
lost in >80% of colorectal cancers and is 
downregulated in some breast and prostate 
cancers24–26. We found that cells preferen‑
tially extruded basally when a truncated 
form of APC associated with tumour 
formation was expressed in either cell 
lines or in zebrafish epidermis22. The APC 
truncation mutant lacks the carboxyl ter‑
minus that binds to both microtubules and 
F‑actin27–29. Because apical extrusion relies 
on coupling micro tubules to cortical actin 
to control where contraction occurs, loss of 
this domain disrupts this targeting, thereby 
driving extrusion basally. APC functions 
cell‑autonomously to drive apical extrusion, 
as expression of the microtubule‑binding 
domain of APC in the extruding cell alone 
is sufficient to rescue apical extrusion in 
colorectal cancer cell lines expressing the 
truncation mutant. This suggests that single 
cells accumulating sporadic APC mutations 
could extrude basally. This new function 
for APC in controlling the direction of 
extrusion could collaborate with its known 
function in driving uncontrolled prolif‑
eration through upregulated WNT signal‑
ling30,31, thereby enabling APC‑mutant cells 
to both invade and proliferate.
Oncogenic KRAS mutations are crucial 
drivers of aggressive tumours, such as 
those of the pancreas, lung and colon32–34. 
When we expressed the oncogenic 
KRASV12G mutation in MDCK (canine 
kidney epithelial cell) mono layers, they 
predominantly extruded basally in a cell‑
autonomous manner23. When grown in 
three‑dimensional cysts surrounded by 
matrix, the basally extruded oncogenic 
KRAS‑mutant cells proliferated into 
smaller cysts or migrated away as single 
cells. Similarly, constitutive mosaic expres‑
sion of oncogenic HRAS in MCF‑10A 
mammary epithelial cell cysts caused cells 
to either basally extrude or lead collec‑
tive cell migration of the neighbouring 
wild‑type cells within the cyst35. Although 
three‑dimensional cultures are more 
representative of in vivo epithelia than 
monolayers, it is not clear how well the 
Matrigel that surrounds these cysts mimics 
the underlying matrix and stroma in real 
tissue. Therefore, the compelling behaviour 
of basally extruded cells from cysts will 
ultimately need to be assessed in vivo to 
determine whether basally extruded trans‑
formed cells can also escape beneath the 
epithelium in real tissue. We have found 
that unlike mutated APC, which disrupts 
microtubules, cells that express oncogenic 
KRAS degrade S1P and partially down‑
regulate S1P2, both of which are required 
for apical extrusion. S1P is degraded owing 
to high levels of autophagy, specifically 
in extruding KRAS‑transformed cells. 
Disruption of autophagy (either geneti‑
cally or chemically) rescued S1P accu‑
mulation and apical extrusion23. Because 
cells expressing oncogenic KRAS rely on 
autophagy for their increased survival36,37, 
current clinical trials are using chloroquine 
(an autophagy inhibitor) to target these 
cells. This treatment could also prevent 
tumour invasion by promoting apical 
Figure 2 | Modes of diverting extrusion basally. a | During wild-type 
apical extrusion, the cell that is destined for extrusion (dark beige), as 
well as its neighbouring cells (light beige), reorient their microtubules to 
the basolateral interface. Reorientation of microtubules in the cell des-
tined for extrusion is required for apical extrusion and presumably 
restricts the biologically active lipid sphingosine-1-phosphate (S1P) to 
the basolateral surface, where it binds to S1P receptor 2 (S1P2) expressed 
in the neighbouring cells to trigger apical extrusion. Microtubule 
reorientation in the neighbouring cells might reinforce RHO- 
mediated actomyosin contraction (arrows) at the basolateral surface. 
b | Mutations in the tumour suppressor adenomatous polyposis coli (APC) 
that disrupt microtubule dynamics can function cell-autonomously in the 
extruding cell to drive extrusion basally. Cell-autonomous apical contrac-
tion of cortical actin and myosin (arrows) at apical epithelial cell junc-
tions can extrude the cell basally into the basement membrane. 
c | Oncogenic KRAS disrupts apical extrusion by downregulating both 
S1P and S1P2. Autophagy degrades S1P, and both S1P puncta and apical 
extrusion can be rescued by disrupting autophagy. Without apical extru-
sion signalling, junctional apical actin and myosin contraction (arrows) 
results in basal extrusion.
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extrusion38. Chloroquine treatment has 
already shown promising results in over‑
coming chemotherapy resistance in human 
HER2 (also known as ERBB2)‑positive 
breast cancers that are also addicted to 
autophagy39. However, mouse models of 
genetically engineered pancreatic cancers 
that lack p53 have found that chloroquine 
treatment can actually exacerbate tumour 
growth40, suggesting some human tumours 
driven by KRAS mutants might also be 
chloroquine‑resistant.
Alternative mechanisms to divert extru-
sion basally. Apart from APC and KRAS, 
other factors that are typically associated 
with poor cancer prognosis could also 
shift the direction in which cells extrude 
from epithelia. Proteins controlling epi‑
thelial cell polarity, such as those in the 
scribble homologue (SCRIB)–lethal giant 
larvae homologue (LGL)–discs large 
homologue (DLG) and partitioning defec‑
tive 6 homologue (PAR6)–PAR3–atypical 
protein kinase C (aPKC) complexes, are 
mutated in numerous carcinomas41 and 
have been linked to their progression 
and metastasis42. Disruption of epithelial 
polarity could randomize the direction in 
which a cell extrudes, thereby increasing 
the incidence of basal extrusion (FIG. 3a). 
Another possibility is that activation of 
basal extrusion alone could occur without 
invoking other signals that activate api‑
cal extrusion (FIG. 3b). In several studies, 
basal extrusion seems to occur as a default 
pathway when apical extrusion fails10,23. 
Although it is not clear what controls 
basal extrusion, one candidate could be 
hyperactivation of RHO, which is associ‑
ated with tumour cell migration43,44,20. It 
is plausible that simply activating RHO 
would cause cells to contract at the apical 
cell–cell junctions, where most actin and 
myosin II exists. In addition, comparatively 
weaker cell–cell or cell–matrix adhesions 
could cause some cells to preferentially 
detach (FIG. 3c). Studies of nanomechani‑
cal forces of single cells, both in vitro 
and from human breast cancer biopsies, 
revealed that metastatic breast tumour cells 
are less stiff than the rest of the tumour 
or surrounding normal tissue45, and this 
can substantially enhance their motility 
in vitro46. Similarly, reduced cell–cell adhe‑
sion by decreased expression of E‑cadherin 
that is found in some metastatic tumours47 
could make these cells more susceptible to 
extrusion than others. Although reduced 
tension of a single cell within an epithe‑
lium under expansion forces could make 
that cell spread, under intrinsic crowding 
forces in regions of extrusion1, it would 
instead be more likely to extrude. Loss of 
E‑cadherin and reduced cell stiffness have 
been linked to metastatic tumours, but 
it is unclear whether these factors drive 
cell extrusion or are a consequence of los‑
ing contact with the epithelium following 
extrusion. Therefore, further studies will 
need to identify what makes a cell suscep‑
tible to extrusion and whether factors that 
promote extrusion do so in a preferentially 
apical or basal manner.
Basal extrusion and tumour invasion
We propose that tumour cells could exploit 
epithelial extrusion as a mechanism to  
Figure 3 | Alternative mechanisms to divert extrusion basally. 
a | Improper localization or disruption of proteins controlling apical–basal 
epithelial cell polarity could increase basal extrusion by randomizing the 
direction in which a cell extrudes and disrupting apical extrusion. For 
example, E-cadherin and partitioning defective (PAR) protein complexes, 
which are crucial for localizing actin and myosin at apical contacts, could 
organize actin elsewhere if polarity is disrupted. b | Cell-autonomous api-
cal contraction (arrows) alone could result in basal extrusion. Although it 
is not clear what activates contraction during basal extrusion, one candi-
date could simply be activation of RHO, which would cause actin and 
myosin — which are typically concentrated apically at adherens junctions 
— to contract at the top of the cell. c | Stiffness of tumour cells has been 
shown to have an important role during cell invasion. Under compressive 
forces, Cells that are less stiff (green), would be more primed to extrude 
than neighbouring, stiffer cells. Similarly, reduced E-cadherin levels, which 
are also associated with metastatic cells, would result in reduced attach-
ment to surrounding cells, and these cells with lower E-cadherin levels 
might be more likely to become detached by extrusion. Although either 
of the above mechanisms could enable cells to extrude apically or basally, 
cells may be more likely to extrude basally, which seems to be the 
default direction in the absence of canonical extrusion signalling. 
S1P, sphingosine-1-phosphate; S1P2, S1P receptor 2.
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initiate invasion into the underlying stroma. 
Current models for how cells escape the 
primary tumour to initiate metastasis fit 
into two broad categories: collective cell 
and single cell invasion21,48,49. The main dif‑
ference between these modes of invasion is 
whether or not tumour cells maintain intra‑
cellular contacts as they migrate through 
the stroma and matrix (BOX 1). Histological 
sections showing streams of cells and sin‑
gle cells emanating from the tumour lend 
support to both types of motility21. In 
considering the hypothesis that tumour 
cells can invade using basal extrusion, it 
is important to establish the fate of trans‑
formed cells after they have extruded 
basally. When we transform MDCK cells 
with oncogenic KRAS, cells that extrude 
basally from cysts show two different 
behaviours: they either migrate away 
singly (FIG. 4a) or they proliferate, thereby 
forming a smaller cyst that is attached 
to the parent cyst23 (FIG. 4b). Therefore, 
basal extrusion of transformed cells could 
enable cells to potentially migrate to other 
sites using either mode of invasion. It 
may be that some cells are primed to lose 
E‑cadherin after extrusion to become more 
mesenchymal‑like or stem cell‑like (FIG. 4a). 
Basal extrusion seems to drive cells to 
dedifferentiate during development, as is 
the case during neuroblast delamination 
from the neuroepithelium in D. melano­
gaster or blood stem cell budding from 
the endothelia of many vertebrates50,18. 
Similarly, in cancer, tumour‑initiating cells 
may bud from the epithelium by basal 
extrusion, thereby increasing their ability 
to proliferate and survive in foreign sites. 
Alternatively, basally extruded cells may 
retain their E‑cadherin, as suggested by the 
ability of extruded cells expressing onco‑
genic KRAS to form new intact cysts. As 
seen in MCF‑10A cysts, an initial basally 
extruded cell with an HRAS mutation 
could lead the collective cell migration of 
other attached cells35. Cells that do not lose 
E‑cadherin expression after basal extrusion 
may still be less differentiated, having more 
intrinsic ability to divide, but restricted to 
an epithelial rather than a mesenchymal 
or pluripotent cell fate. Given the right 
cues in vivo, these cells could undergo col‑
lective cell migration rather than simply 
divide (FIG. 4b). Although epithelia that are 
cultured in three dimensions behave more 
like epithelia in vivo, they lack the complex 
components of real tissue. Thus, future 
work will need to determine whether 
basal extrusion could drive either single 
or collective cell migration in an in vivo 
model system.
An important point that distinguishes 
basal extrusion from the other models is 
that extrusion of cells can occur away from 
the main tumour mass (FIG. 4a,b). We have 
found that although oncogenic KRAS can 
drive cells to lose contact inhibition, the 
sites where cells basally extrude are not 
necessarily the same as the areas where 
masses form23. This could account for why 
pancreatic, colon and lung tumours that 
are driven by KRAS are typically metastatic 
with poor prognosis. The idea that tumours 
could metastasize independently of a pri‑
mary tumour is alarming but not unheard 
of 51,52. Indeed, molecular profiling of diff‑
erent tumour types suggests that some 
tumours develop with higher likelihoods 
of metastasizing than others53–56. Although 
transformed cells could invade at sites 
that are distinct from the primary mass 
using epithelial‑to‑mesenchymal transi‑
tion (EMT) or collective cell migration, the 
invasive aspects in these models typically 
derive from general loss of epithelial organ‑
ization and compressive forces that arise in 
surrounding tissue owing to growth of the 
primary tumour.
Concluding remarks
It is not clear why some tumours metas‑
tasize, whereas others do not. Our under‑
standing of tumour invasion is mitigated 
by our ability to capture the natural for‑
mation and invasion of a tumour from an 
epithelium in vivo. Two‑photon confocal 
intravital imaging of mammary mouse 
tumours has provided unprecedented reso‑
lution of migrating tumour cells in vivo57–62. 
One caveat to this approach, however, is 
the necessary introduction of a wound to 
provide a window for microscope access  
to the tumour, which could result in signal‑
ling and inflammation that is not present 
in naturally occurring tumours63. Future 
studies using zebrafish could provide an 
excellent animal model to directly visualize 
tumours invading directly from epithelia, 
as embryos are transparent and can be 
readily imaged without the invasive 
techniques that are intrinsic to current 
tumour models64. The zebrafish epider‑
mis provides an excellent model for the 
epithelial bilayer that encases lungs and 
Box 1 | Current models of carcinoma invasion
EMT: invasion of single tumour cells from a mass
Epithelial-to-mesenchymal transition (EMT) might provide a mechanism by which some single cells 
disseminate from an epithelial tumour mass47,67,68 (see the figure, part a). During EMT, tumour  
cells downregulate E-cadherin (thereby weakening cell–cell adhesions) and migrate away as  
single cells. The loss of E-cadherin and activation of matrix-degrading proteases changes cell 
behaviour to be more mesenchymal, which allows these cells to adapt and survive in different parts 
of the body, independently of normal epithelial survival signals. EMT could promote the 
dedifferentiation of cells into stem cells in development and cancer67,69. Mesenchymal cells could 
then transdifferentiate to an epithelial phenotype in different sites within the body to promote 
metastatic outgrowth. Several types of carcinomas with poor prognosis express various inducers of 
EMT, such as snail homologue 1 (SNAI1) and SLUG (also known as SNAI2), TWIST, and zinc finger 
E-box-binding homeobox 1 (ZEB1) and ZEB2, which downregulate E-cadherin, and this supports the 
idea that tumours use EMT to initiate invasion.
Collective tumour cell invasion from a mass
Tumour cells have been seen emanating in streams from a tumour cell mass in what is termed 
collective cell migration21,48,70 (see the figure, part b). Cells can migrate as a continuous mass 
that disseminates from the primary tumour or as smaller discontinuous cohorts of nearby 
cells. Unlike single cells that invade by EMT, these cells maintain cell–cell adhesions and are 
cohesive as they migrate. Migration of a cell front requires degradation of the matrix and the 
secretion of matrix-degrading proteases. Owing to histological evidence and the fact that 
most metastases retain E-cadherin, most metastatic carcinomas are thought to migrate 
collectively.  
In addition, it is 
thought that 
metastatic cells 
may alter their 
ability to 
migrate singly or 
collectively, 
depending  
on the matrix and 
the tissue that 
they encounter.
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mammary glands. We are developing tools 
to label, knock down and express genes 
in single cells, where we can directly fol‑
low cells dividing, migrating and invad‑
ing from the epithelium in situ (G.M.S., 
A. V. Gardner, G. Eisenhoffer and J.R., 
unpublished observations). Additionally, a 
new method to test the metastatic potential 
of human tumours has been developed 
in zebrafish embryos65,66. In this model, 
within only 48 hours after injecting can‑
cer cells into the yolk sacs of 2‑day‑old 
zebrafish embryos, the metastatic potential 
was found to mimic mouse xenografts 
that were observed over the course of 
2 months54, and this zebrafish model 
allows tumour cell dissemination to be 
filmed live.
Once a tumour cell has gained access to 
the circulation, the extravasation, survival 
and establishment of micrometastases in a 
distal organ are thought to be surprisingly 
efficient4. Therefore, identifying whether 
tumour cells use basal extrusion to initiate 
invasion into the underlying stroma before 
entering the circulation is of crucial impor‑
tance to our understanding of metastasis. 
Understanding the molecular and genetic 
profiles of cells that can extrude basally 
and survive might help us to define the 
metastatic potential of some tumours. 
Furthermore, identifying whether basal 
extrusion might be enhanced with zinc 
finger E‑box‑binding homeobox 1 (ZEB1), 
snail homologue 1 (SNAI1) and SLUG (also 
known as SNAI2), which drive EMT, or 
with matrix metalloproteinases, which are 
typically upregulated with collective cell 
migration, will be important to determine 
the relationship of extrusion to these previ‑
ously defined invasion modes. New imaging 
methods that allow us to follow metastases 
from their initial local invasion to their 
colonization in distant organs will also be 
important for determining how cells invade 
and migrate and whether basal extrusion is 
a crucial step in this process. A better under‑
standing of how different tumours invade 
will be essential for preventing their spread.
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Introduction
To preserve epithelial barrier function during cell turnover, 
dying cells are shoved out of the epithelium by a process we 
have termed “apoptotic cell extrusion” (Rosenblatt et al., 2001). 
Here, the cell destined for apoptosis signals its live neighbor-
ing epithelial cells to form a ring of actin and myosin II that 
contracts to squeeze the dying cell out of the epithelial sheet. 
This contraction not only ejects the dying cell out of the layer 
but also closes any gaps that may have resulted from the dying 
cell’s exit.
Importantly, cells can be extruded either apically into the 
lumen or basally back into the tissue the epithelia encases. 
Previously, we only detected apical extrusion of apoptotic 
cells from the epithelia encasing vertebrate embryos and adult 
organs. However, we nd that basal extrusion occurs occasion-
ally in vertebrates and commonly in Drosophila embryonic epi-
thelia (also see Gibson and Perrimon, 2005; Vidal et al., 2006; 
Ninov et al., 2007). The direction a cell is extruded is important 
for its fate, as corpses extruded basally must be engulfed, 
whereas those extruded apically may be expelled or trapped in 
the lumen. Extrusion direction is likely more important in cases 
where cells are blocked from death but still extrude. Apical 
extrusion would still eliminate these cells, whereas basal 
extrusion could allow live cells to be retained in the tissue to 
potentially migrate elsewhere. Because this decision is critical 
for the extruded cell’s fate, we sought to identify the molecular 
mechanism that determines the direction a cell will extrude.
Although our previous work had established the fact that 
apoptotic cell extrusion requires Rho-mediated contraction of 
an intercellular actin/myosin II ring in the cells surrounding the 
dying cell (Rosenblatt et al., 2001), we did not examine how 
actin/myosin contraction is organized to squeeze the dying cell 
out apically into the lumen. Further, we did not notice the minor 
populations of apoptotic cells that extruded basally in tissue 
culture monolayers. Here, we analyze how actin and myosin 
contraction is regulated differently when cells extrude apically 
versus basally using cultured epithelial monolayers from canine 
kidney, MDCK, or human bronchia (16-HBE-14o), as well as 
the epidermis of live zebrash. We nd that apical extrusion 
requires reorientation of microtubules and associated p115 
RhoGEF basolaterally, which activates Rho to contract actin/
myosin basally and squeeze the dying cell out.
To preserve epithelial barrier function, dying cells are squeezed out of an epithelium by “apoptotic cell extrusion.” Specifically, a cell destined for 
apoptosis signals its live neighboring epithelial cells to 
form and contract a ring of actin and myosin II that 
squeezes the dying cell out of the epithelial sheet. 
Although most apoptotic cells extrude apically, we find 
that some exit basally. Localization of actin and myosin 
IIA contraction dictates the extrusion direction: basal 
extrusion requires circumferential contraction of neigh-
boring cells at their apices, whereas apical extrusion 
also requires downward contraction along the baso-
lateral surfaces. To activate actin/myosin basolaterally, 
microtubules in neighboring cells reorient and target 
p115 RhoGEF to this site. Preventing microtubule re-
orientation restricts contraction to the apex, driving 
extrusion basally. Extrusion polarity has important impli-
cations for tumors where apoptosis is blocked but extru-
sion is not, as basal extrusion could enable these cells 
to initiate metastasis.
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that epithelial polarity is not markedly altered when cells ex-
trude basally versus apically.
To examine where actin/myosin contraction occurred, we 
immunostained extruding monolayers with a phospho-myosin 
II antibody that recognizes only actively contracting myosin II 
(Matsumura et al., 1998). We nd that myosin IIA contraction 
is active along the basolateral interface between the apoptotic 
cell and its neighboring cells during apical extrusion but is 
restricted to the apical interface during basal extrusion (Figs. 2 c  
and S1, control). Localization of phospho-myosin II and 
videos of extrusion suggest that all extrusion events require co-
ordinated, circumferential contraction of the cortical actin and 
myosin II at the cell–cell contacts that interface with the dying 
cell. The difference in whether extrusion occurs apically rather 
than basally appears to be linked to whether basolateral contrac-
tion also occurs at this ring.
If extrusion direction corresponds to where myosin 
II assembles and contracts, what controls its localization? 
Because microtubules have been found to activate or in-
hibit myosin II contraction in cytokinesis and other con-
tractile processes (Wittmann and Waterman-Storer, 2001; 
Matsumura, 2005), we examined whether microtubules regu-
late myosin II contraction during extrusion. Live 3D videos 
of mApple-actin and GFP-tubulin show that microtubules 
dynamically reorient toward the actin-extruding ring early 
and throughout extrusion process, but retract once extru-
sion is complete during both apical and basal extrusion (see 
Videos 8 and 9, respectively). Because microtubules grow 
dynamically toward the ring, we reasoned that the plus 
ends of microtubules reorient toward the ring and activate 
myosin II contraction. To confirm that microtubule plus 
ends abut where actin and myosin contract during both api-
cal and basal extrusion, we immunostained fixed, extrud-
ing monolayers for EB1, a plus-end microtubule-binding 
protein (Carvalho et al., 2003), myosin II, and DNA. Many 
EB1 spots localized to the basolateral surface during apical 
extrusion (Fig. 3 A, 3–6 µm from base), whereas far fewer 
EB1 spots localize to the apex during basal extrusion (Fig. 3 B, 
≥6 µm from the base). Quantification confirmed that more 
EB1 spots localized to the basolateral surface (0–4 µm from 
base) than the apical surface (4–8 µm from base) of the actin 
ring during apical extrusion compared with basal extrusion 
or to live cell–cell contacts, labeled “junction” (Fig. 3 C). 
These experiments suggest that microtubules in the cells 
surrounding an apoptotic cell dynamically reorient toward 
the basolateral surface that contacts the dying cell during 
apical extrusion.
To test if microtubule reorientation toward the dying 
cell is required for basolateral contraction during api-
cal extrusion, we used inhibitors to disrupt microtubules 
and analyzed xed, immunostained extruding monolayers. 
Destabilizing microtubules with nocodazole reduced the 
number of apoptotic cells that extruded (no contraction) 
and increased the percentage that extruded basally (Fig. 4, 
a and b). To block the reorientation of microtubules toward 
the basal surface during apical extrusion, we treated extrud-
ing monolayers with the microtubule-stabilizing drug taxol. 
Results and discussion
Using MDCK and 16-HBE-14o epithelial lines treated with 
UV254 to induce apoptosis, we found that although most apop-
totic cells extrude apically, a small fraction extrudes basally. 
The direction of extrusion is apparent in the stills from phase 
videos (Fig. 1 and associated Videos 1–3). During apical ex-
trusion, the cell body is pushed out of the monolayer into the 
medium (Fig. 1 a and Video 1), whereas during basal extrusion, 
the cell becomes trapped between the monolayer and the cover 
glass and migrates underneath the monolayer (Fig. 1 b and 
Videos 2 and 3). Because epithelial monolayers in culture may 
have articially strong adhesion to glass, we wanted to assess 
if similar ratios of apical versus basal extrusion also occurred 
in vivo. We have found that zebrash larval epidermises pro-
vide an excellent model system to follow extrusion live, which 
can also be manipulated with inhibitors. G-418 treatment of 
4-d-old zebrash larvae induces dying cells that predominantly 
extrude apically from the epidermis (Fig. 1 c and Video 4). 
Apically extruded cells exit into the sh water, whereas ba-
sally extruded cells become trapped beneath the epidermis 
(Fig. 1 d and Video 5).
We visually scored apical versus basal extrusion in UV-
treated, fixed monolayers (referred to as “extruding mono-
layers”) and zebrafish epidermises by assessing the location 
of the actin-extruding ring compared with the extruded 
body, marked by compacted DNA and activated caspase-3 
staining (see Fig. 1, e and f for examples of apical and basal 
extrusion in MDCKs; and see Videos 6 and 7 and Fig. S2 for 
examples in zebrafish). During apical extrusion, the actin 
ring is thicker and extends to the base of the cell, whereas 
active caspase-3 and DNA (marking the extruded cell) are 
apical to the ring. In contrast, during basal extrusion, the 
actin ring is apical and similar in intensity to the cortical 
actin at adherens junctions in the live cells, and the caspase-3 
and DNA are basal to the contracted apical ring. Using these 
hallmarks for examining the polarity of extrusion, we found 
that zebrafish and tissue culture epithelia predominantly ex-
trude apoptotic cells apically. 89 ± 2.3% (SEM) from >500 
extruding cells (n = 4 experiments) from zebrafish epider-
mises, 80 ± 6% (SEM) of 1,250 extruding cells (n = 5 ex-
periments) from MDCK monolayers, and 79 ± 9% (SEM) of 
700 extruding cells (n = 7 experiments) from 16-HBE-14o 
monolayers extruded apoptotic cells apically; the remainder 
extruded basally.
What determines whether cells are extruded apically or 
basally? Two models for differentially regulating the direc-
tion are: (1) the intrinsic polarity of neighboring cells may 
be altered or lost, positioning cortical actin differentially; or 
(2) actin and myosin may be independently localized apically 
or basally. To examine if polarity was altered when cells ex-
truded apically versus basally, we immunostained extruding 
monolayers for the apical tight junction protein, ZO-1, and 
the basolateral adherens junction protein, ?-catenin (Yu et al., 
2005). ZO-1 remained apical and ?-catenin basal during either 
apical or basal extrusion (Fig. 2, a and b, respectively). The 
preserved localization of polarized adhesion markers suggests 
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dynamics shifted the balance of extrusions from apical to 
basal even more dramatically in zebrash larval epidermises 
(from 89 ± 2.3% [SEM] to 27 ± 1.3% [SEM] in control vs. 
taxol treatments, from >900 extruding cells over four separate 
experiments, P < 0.0001). The drug treatments suggest that 
In contrast to control-treated cells, taxol treatment blocked 
microtubule reorientation toward the base of the dying cell 
(Fig. 4 a). Additionally, taxol treatment of monolayers shifted 
the direction of extrusion from predominantly apical to 
basal (Fig. 4 b). We found that disruption of microtubule 
Figure 1. Hallmarks of apical and basal apoptotic cell extrusion. Stills from phase videos of apoptotic cells extruding apically (a and c) and basally (b and d) 
in an MDCK cell culture epithelium (a and b) and from a zebrafish larval epidermis (c and d; teal arrows denote extruding cells). Time is given in hours 
and minutes. (e and f) An apoptotic cell extruding apically (e) and basally (f), immunostained for active caspase-3 (green), actin (red), and DNA (blue). 
Note that caspase and DNA are in the top z plane and a thick actin ring is in the bottom plane when a cell is extruded apically (e), whereas the actin ring 
is in the top plane and caspase and DNA are in bottom plane when extruding basally (f). Bars, 10 µm.
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basally, but if microtubules are allowed to reorient toward 
the base, contraction occurs along the basolateral surface, 
driving extrusion apically.
actin and myosin II contract at sites where microtubules con-
tact the cortex. When microtubules are frozen at the apex, 
actin/myosin II contract at the apex and drive extrusion 
Figure 2. Localization of active myosin IIA but not intrinsic polarity markers are altered when cells are extruded apically or basally. (a and b) Cross sec-
tions of tight junction protein Z0-1 (a), which remains apical, and ?-catenin (b), which remains basal. (c) Myosin IIA and phospho-myosin II are basolateral 
during apical extrusion and apical during basal extrusion. Cross sections are taken from the broken line in pictures of 3D confocal reconstructions of MDCK 
cells. Arrows point to dying, extruded cells in each case. Bars, 10 µm.
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Because Rho activation in neighboring cells is required 
for extrusion contraction (Rosenblatt et al., 2001) and be-
cause microtubules can regulate several RhoGEFs (Krendel 
et al., 2002; Rogers et al., 2004), we hypothesized that micro-
tubules could regulate extrusion direction by locally activating 
Rho. Total RhoA protein localized throughout the live–dead 
cell interface, although myosin II contraction occurred only 
at the bottom of the actin/myosin ring during apical extru-
sion (Fig. 5 a, bottom), suggesting that Rho activation is re-
stricted to the basolateral surface. Because the Drosophila 
To determine if basolateral microtubule reorientation local-
izes myosin II or its activators to this surface, we immunostained 
extruding monolayers treated with nocodazole or taxol for myo-
sin II and phospho-myosin II. Both myosin II and phospho-myosin 
II localized to the extruding ring in control-treated monolayers 
but were substantially reduced in the presence of nocodazole, 
and restricted to the apex in the presence of taxol (Fig. S1). 
Disruption of both myosin II localization and activation with 
microtubule inhibitors suggests that microtubules promote both 
assembly and activation of the actin/myosin ring.
Figure 3. The growing ends of microtubules point toward the actin/myosin ring during extrusion. (a and b) EB1 (green), a plus-end microtubule- 
binding protein, colocalizes with the myosin II (red) ring during apical (a) and basal (b) extrusion. Arrows point to sites where EB1 abuts the myosin II 
ring. Note that most EB1 is from 0–4 µm from the base during apical extrusion, whereas during basal extrusion, only limited amounts of EB1 are seen at 
the apex (6 µm from the base). Bars, 10 µm. (c) Quantification of EB1 localization (>170 spots for each) from 12 extrusions each of apically extruding 
cells, basally extruding cells, and live junctions. Error bars indicate SEM and P < 0.0001, comparing spots from apical extrusion to basal extrusion.
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RhoGEF siRNA had no effect on extrusion direction (Fig. 5 b). 
The percentage of cells that shifted from predominantly api-
cal to basal was similar to that seen with taxol treatment, 
which is consistent with p115 RhoGEF and microtubules acting 
in the same pathway.
Moreover, p115 RhoGEF, unlike RhoA, localizes only 
to sites of active myosin II contraction during both apical and 
basal extrusion. p115 RhoGEF appears in bers that point to 
the base of the extruding ring during apical extrusion (Fig. 5 a, 
top; and Fig. 5 c). Unlike RhoGEF2 that localizes to micro-
tubule tips (Rogers et al., 2004), we found that p115 RhoGEF 
colocalizes along microtubules, suggesting that it either as-
sociates with microtubules or with a microtubule-associated 
RhoGEF2 associates with microtubule plus ends to drive 
Rho-mediated actin/myosin contraction during gastrulation 
(Rogers et al., 2004), we investigated whether members of the 
regulator of G protein signaling (RGS) family of RhoGEFs, 
mammalian homologues of RhoGEF2 (Fukuhara et al., 2001), 
were required for apical extrusion. We treated 16-HBE-14o 
monolayers with siRNAs directed against PDZ RhoGEF, p115 
RhoGEF, and leukemia-associated RhoGEF (LARG), and as-
sayed the direction of extrusion in the resulting monolayers. 
Knockdown of PDZ and LARG RhoGEFs had no obvious 
effect on extrusion direction (Fig. S3, a and b). However, 
knockdown of p115 RhoGEF dramatically reduced the per-
centage of apically extruding cells, whereas scrambled p115 
Figure 4. Disruption of microtubules alters the direction a cell extrudes. (a) In control (DMSO-treated) MDCK monolayers, microtubules dip down toward 
the basolateral surface of the actin ring, whereas nocodazole either blocks contraction of the ring (as shown) or drives extrusion basally. Stabilizing micro-
tubules with taxol freezes microtubules at the apex compared with control and drives extrusion basally. Broken lines indicate the site of cross sections from 3D 
confocal reconstructions above. Bars, 10 µm. (b) Quantification of drug-treatments from six experiments, n = 1,350 extruding cells per treatment. P-values 
for apical and basal extrusions, respectively, were 0.0011 and 0.0066 for nocodazole and 0.0023 and 0.0023 for taxol. Error bars indicate SEM.
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Figure 5. p115 RhoGEF is required for apical extrusion. (a) p115 RhoGEF (red; separate middle panel) form filaments that point toward the basolateral 
surface of the extruding ring during apical extrusion, whereas RhoA (green; bottom panel) is present through the apical and basal regions of the ring. Cor-
responding colored arrows indicate sites of interaction with the actin/myosin ring. Bar, 10 µm. (b) siRNA-mediated knockdown of p115 RhoGEF (above, 
lanes from one immunoblot) disrupts apical extrusion, whereas scrambled siRNA does not. The graph shows the percentage of apical versus basal extrusion 
from >1,000 cells from four siRNAs experiments, where P < 0.0001. (c) p115 RhoGEF localizes to the base of the extruding ring during apical extru-
sion, whereas it does not when microtubules are disrupted with nocodazole or taxol, or in control live junctions, where P-values are <0.0001 for control 
versus each treatment; n = 10 extrusions per treatment. (d) Model for how microtubules might control extrusion direction. An early apoptotic cell sends 
signals to its live neighboring epithelial cells, which react by reorienting microtubules toward the basolateral surfaces of the cells that contact the dying 
cell. p115 RhoGEF, by association with microtubules, assembles and activates Rho-mediated actin and myosin II contraction along the basolateral surface, 
extruding the cell apically (top). Basal extrusion occurs if the microtubules do not reorient or if p115 RhoGEF is absent (bottom).
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death with a caspase inhibitor does not block cell extrusion 
(Rosenblatt et al., 2001). Further, many high-grade epithelial 
tumors have mutations in apoptosis (Yang et al., 2003; Schulze-
Bergkamen and Krammer, 2004; Meulmeester and Jochemsen, 
2008) that would block apoptosis at steps we predict would not 
block extrusion.
In situations where cells can extrude without dying, the 
direction a cell extrudes is pivotal for its fate. In cancer, apical 
extrusion could act as a tumor suppressor, eliminating tumor 
cells through the lumen. Even in cases where tumors cells accu-
mulate in a closed lumen, such as in breast ductal carcinoma in 
situ, they rarely invade and metastasize (Kopans et al., 2003). 
Basal extrusion, however, could provide an exit path for these 
tumor cells to initiate metastasis and migrate to other sites in the 
body. Evidence for basal extrusion promoting invasion exists in 
Drosophila larvae and pupae when cell death is blocked, as 
extrusion in these tissues occurs almost exclusively basally 
(Pagliarini and Xu, 2003; Gibson and Perrimon, 2005; Thompson 
et al., 2005; Vidal et al., 2006; Ninov et al., 2007; Hogan et al., 
2009). Further work will test if basal extrusion of tumor 
cells could enable their invasion and metastasis through the 
matrix and into the bloodstream in vertebrates. Our results iden-
tifying a role for microtubules in regulating the direction of 
extrusion in zebrash will allow us to follow the fate of basally 
extruded live cells in a vertebrate model where single cells can 
be readily imaged and tracked (Redd et al., 2006).
Materials and methods
Cell culture
MDCK II cells (gift from K. Matlin, University of Chicago, Chicago, IL) were 
cultured in Dulbecco’s minimum essential medium (DMEM) high glucose 
with 5% FBS and 100 µg/ml penicillin/streptomycin (all from Invitrogen) at 
5% CO2, 37°C. 16-HBE-14o (provided by D. Gruenert [California Pacific 
Medical Center, San Francisco, CA] and J. Porter [University College Lon-
don, London, England, UK]) were cultured in MEM containing Earle’s salts, 
1 g/liter glucose, 2.2 g/liter NaHCO3, L-glutamine, 10% FBS, and 
100 µg/ml penicillin-streptomycin (Invitrogen) in a flask coated with human 
fibronectin type I (BD), bovine collagen I (Purecol; Inamed biomaterials), and 
BSA (Invitrogen) at 5% CO2, 37°C.
Transfections
siRNAs were synthesized at the University of Utah oligo and peptide 
synthesis core to the following sequences: p115 RhoGEF (5?-GCAGCU-
CUGAGAACGGCAA-3?), LARG RhoGEF (5?-GAAACUCGUCGCAU-
CUUCC-3?), PDZ RhoGEF (5?-ACUGAAGUCUCGGCCAGCU-3?), and 
scrambled control siRNA (5?-UUCUCCGAACGUGUCACGU-3?). Antisense 
and sense duplexes LARG RhoGEF and P115 RhoGEF were annealed in 
100 mM potassium acetate, 30 mM Hepes-KOH, 2 mM magnesium acetate, 
pH 7.4, and PDZ RhoGEF duplexes in 50 mM Tris, pH 8.0, and 100 mM 
NaCl at 90°C for 1 min and 37°C for 1 h. 50 pMol (LARG and P115) or 
30 pMol (PDZ) siRNAs were transfected by nucleofection using the solution 
V-program G016 (Amaxa) or by RNAimax Reverse Transfection according to 
the manufacturer’s instructions (Invitrogen). We also confirmed our results 
using two independent shRNAs directed against p115, PDZ, and LARG 
RhoGEFs (gift from A. Jaffe [Novartis, Boston, MA] and A. Hall [Memorial 
Sloan Kettering Cancer Center, New York, NY]).
Cell staining
For EB1 and myosin IIA staining, cells were fixed with 100% methanol 
at ?20°C for 45 s. For RhoGEF p115 staining, monolayers were pre-
permeablized with PBS with 0.1% Triton X-100 containing 1 µg/ml phal-
loidin for 60 s before fixation with 4% formaldehyde in PBS at 37°C 
for 20 min. For all other immunostainings, cells were fixed with 4% 
formaldehyde in PBS at 37°C for 20 min. Fixed cells were rinsed three 
times in PBS, permeabilized for 5 min with PBS containing 0.5% Triton 
matrix (Fig. S3 c). To test if p115 RhoGEF localization was 
dependent on microtubules, we quantied the number of p115 
RhoGEF bers in control-extruding monolayers compared with 
nocodazole or taxol-treated monolayers. Compared with control-
treated monolayers, taxol treatment restricted p115 RhoGEF 
to the apex (Figs. 5 c and S3 d, for a representative picture), 
whereas nocodazole treatment eliminated p115 RhoGEF at 
the dying cell, similar to levels seen at live cell–cell junctions 
(Figs. 5 c and S3 e). These results suggest that microtubules 
localize p115 RhoGEF to activate basolateral contraction dur-
ing apical extrusion. Although Rho exists throughout the ring, 
and microtubules and p115 span the extruding live cells, Rho is 
activated only at sites where it intersects with p115 RhoGEF.
Based on the effects of disrupting microtubules and p115 
RhoGEF on the direction of extrusion, we propose a model for 
how microtubules control the direction of extrusion (Fig. 5 d). 
When cells are extruded apically (Fig. 5 d, top), the cells sur-
rounding a cell destined to die reorient their microtubules to-
ward the basolateral surfaces that interface with the dying cell. 
Microtubules target p115 RhoGEF to the basolateral surface, 
where it activates Rho, present at the live–dead cell interface, to 
assemble and activate myosin IIA contraction. The extrusion 
ring contracts circumferentially around the dying cell as well as 
basolaterally to squeeze the apoptotic cell out apically. Failure 
of p115 RhoGEF to target to the basolateral surface, either by 
its knockdown or by disruption of microtubule reorientation, 
results in basal extrusion (Fig. 5 d, bottom). Here, actin and 
myosin IIA already present at apical adherens junctions could 
readily contract circumferentially around the dying cell. How-
ever, because basolateral actin/myosin contraction is absent, 
contraction is restricted to the apex, forcing the apoptotic cell 
out basally. During both types of extrusion, adherens and tight 
junctions are maintained above the sites of contraction, which 
preserves the barrier function of the epithelium throughout the 
extrusion process (as seen in Fig. 2, a and b).
Although we have found that microtubule reorientation is 
important for apical extrusion, microtubule disruption did not re-
verse the extrusion direction in 100% of cells, which suggests 
that other factors may also contribute to extrusion polarity. The 
extrusion polarity effects from taxol treatment were more dra-
matic in zebrash than in culture, which suggests that this deci-
sion is regulated more tightly in vivo. Other factors affecting 
extrusion polarity may include matrix, intrinsic polarity, or cell 
height. A more adhesive surface may encourage apical extrusion, 
whereas basal extrusion might dominate in monolayers on a less 
adhesive substratum. Taller epithelia, such as in the gut, would 
likely show more dramatic effects in extrusion polarity than 
would atter epithelia.
Several observations suggest that extrusion may not be 
limited to apoptotic cells, but could be a common mechanism 
for living cells to exit an epithelium without disrupting epithe-
lial function. Apoptotic extrusion looks morphologically similar 
to developmental events where single cells exit the epithelium, 
such as neuroblast delamination in Drosophila melanogaster 
(Hartenstein et al., 1994). Here, cells exit the neuroepithelium 
and, instead of dying, divide asymmetrically before differentiat-
ing into neurons. We have previously found that blocking cell 
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in 12 randomly selected cell extrusions (>170 z sections). The number of 
EB1 spots at the base was averaged from the bottom 12 of 24 z sections 
and at the apex from the top 12 of 24 z sections, where the error bars 
indicate SEM from the variation of 12 separate apical and basal extru-
sions, and 12 cell–cell contacts where p-values from a t test are <0.0001 
for apical versus basal extrusion. For quantification of p115 RhoGEF fibers 
intersecting with the extruding ring, we created montages (as described in 
the image acquisition section) and manually counted the number of p115 
RhoGEF spots abutting the extrusion ring in the first 0–4 µm (base) and the 
next 4–8 µm (apex) from the bottom of the cell. Statistical analysis was 
done on 10 separate extrusions from control, nocodazole, taxol, and junc-
tions from each, where error bars represent the SEM and the p-values from 
a t test are <0.0001 for each compared with the control.
Online supplemental material
Fig. S1 shows that disruption of microtubules mislocalizes myosin IIA and 
phospho-myosin II in 16-HBE-14o cell monolayers. Fig. S2 shows that taxol 
treatment induces basal extrusion in zebrafish larval epidermis. Fig. S3 
shows that siRNA-mediated knockdown of other RGS-RhoGEFs has no 
effect on the direction of extrusion, and that disruption of microtubules dis-
rupts localization of RhoGEF p115. Videos 1–3 show typical basal and 
apical extrusion from MDCK cell monolayers. Videos 4–7 shows apical 
and basal extrusion from the epidermis of 4-d-old zebrafish. Videos 8–9 
show apical and basal extrusion, respectively, in MDCK cells expressing 
mApple-actin and GFP-tubulin. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200903079/DC1.
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Figure S1. Disruption of microtubules with nocodazole or taxol mislocalizes both myosin IIA and phospho-myosin II in 16-HBE-14o cell monolayers. Both 
phospho-myosin II and myosin IIA localize throughout the extruding ring in control monolayers, but are absent in nocodazole and restricted to the apex in 
taxol-treated monolayers. Cross sections above are from the broken lines in the xy images. Bars, 10 µm.  on Septem
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Figure S2. Freezing microtubules with taxol drives extrusion basally in zebrafish larval epidermis. Treatment of 4-d-old zebrafish larvae with G-418 
to induce apoptosis and with taxol to stabilize microtubules drives extrusion basally. Note that the actin (red) ring is at the top (apex) of fish and the con-
densed DNA (blue) is basal, where numbers represent micrometers from the most apical part of ring. At this stage, active caspase-3 (green) is dim, but 
will become brighter later as the cell extrudes (as seen in Video 7). Bar, 10 µm
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Figure S3. siRNA-mediated knockdown of other RGS-RhoGEFs has no effect on the direction of extrusion. (a) Immunoblots of LARG and PDZ RhoGEF 
knockdown (lanes from same blot). (b) Graphs representing the mean of five different experiments analyzing 1,000 extruding cells for their extrusion direc-
tion for each knockdown. (c) p115 RhoGEF and microtubules colocalize near the extrusion ring. Bar, 1 µm. (d and e) Treatment with taxol (d) or nocodazole 
(e) disrupts basolateral distribution of p115 RhoGEF (red; middle panels) and RhoA (green; bottom panels), where arrows point to the dying cell (DNA is 
blue). p115 RhoGEF localization with each treatment is quantified in Fig. 5. Bars, 10 µm.
Video 1. An apoptotic cell extruding apically from an MDCK cell monolayer. The cell that will extrude is marked by a blue 
arrow in the beginning frame. Frames were taken every 60 s using a 40× 0.75 NA Nikon phase lens.
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Video 2. An apoptotic cell extruding basally from an MDCK cell monolayer. Note that the cell that extrudes basally (arrow 
in the beginning frame) appears to migrate under the monolayer, and presumably is later engulfed. Frames were taken every 
60 s using a 40× 0.75 NA Nikon phase lens.
Video 3. Another apoptotic cell extruding basally from an MDCK cell monolayer. Note that the cell that extrudes basally 
(arrow in beginning frame) appears to migrate under the monolayer, and presumably is later engulfed. Frames were taken 
every 60 s using a 40× 0.75 NA Nikon phase lens.
Video 4. Apical extrusion of a dying cell from the epidermis of a 4-d-old zebrafish. The dying cell extrudes apically out of the 
epidermis and is trapped between fish and cover glass when zebrafish 4-d-old larvae are treated with 450 µg/ml G-418 and 
0.2% DMSO (as carrier control). Frames were taken every 60 s using a 40× 0.8 W Nikon water immersion DIC lens.
Video 5. Basal extrusion of a dying cell in the epidermis of a 4-d-old zebrafish treated with taxol. The dying cell extrudes 
basally into the epidermis and is trapped beneath the epidermis when zebrafish larvae are treated with 450 µg/ml G-418 and 
20 µM taxol. Frames were taken every 60 s using a 40× 0.8W Nikon water immersion DIC lens.
Video 6. Apical extrusion of a dying cell from the epidermis of a 4-d-old zebrafish: 3D reconstruction. An apoptotic cell (with 
active caspase-3 staining; green) is extruded out of the plane, where actin ring (red) is below the cell and its DNA (blue). Shown 
is a tilting reconstruction of confocal projections from a z series taken on a TCS SP5 confocal microscope (Leica) using a 63× 
oil lens at 1,024 × 1,024 resolution.
Video 7. Basal extrusion of a dying cell into the epidermis of a 4-d-old zebrafish: 3D reconstruction. An apoptotic cell (with 
active caspase-3 staining; green) is extruded out of the plane, where actin ring (red) is above the caspase-positive cell and its 
DNA (blue). Tilting reconstruction of confocal projections from a z series taken on a TCS SP5 confocal microscope (Leica) using 
a 63× oil lens at 1,024 × 1,024 resolution.
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Video 8. Apical extrusion in MDCKs expressing mApple-actin and GFP-tubulin. Microtubules (green) target toward the extrud-
ing actin ring (red) early during the extrusion process and remain throughout until the ring has closed. Then, the microtubules 
retract from this point. The video was acquired with an inverted microscope (Nikon) with a 60× lens using a spinning disc 
system (Yokogawa) and a cooled CCD camera (Andor 1000). Four z-section planes were taken through 9 µm and projected 
together using 4D software from Andor. The entire video represents 1 h.
Video 9. Basal extrusion in MDCKs expressing mApple-actin and GFP-tubulin. Microtubules (green) target toward the top of 
the extruding actin ring (red) throughout the extrusion process. Note that far fewer microtubules target the actin/myosin ring 
than in the apical extrusion case (Video 8). The video was acquired with an inverted Nikon with a 60× lens using a spinning 
disc system (Yokogawa) and a cooled CCD camera (Andor 1000). Four z-section planes were taken through 9 µm and pro-
jected together using 4D software from Andor Technologies. The entire video represents 1 h.
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4  CHAPTER 3
ONCOGENIC K-RAS PROMOTES BASAL EXTRUSION OF EPITHELIAL 
CELLS BY DEGRADING S1P THROUGH AUTOPHAGY
Reprinted with permission from Current Biology. Slattum, G., Gu, Y., Sabbadini, R., 
and Rosenblatt, J. (2014). Oncogenic K-Ras promotes basal extrusion of epithelial 
cells by degrading S1P through autophagy. Current Biology. Jan 6;24(1):19-28.
Chapter 3 is a published article. 
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Summary
Background: To maintain a protective barrier, epithelia
extrude cells destined to die by contracting a band of actin
and myosin. Although extrusion can remove cells triggered
to die by apoptotic stimuli, to maintain constant cell numbers,
epithelia extrude live cells, which later die by anoikis. Because
transformed cells may override anoikis and survive after extru-
sion, the direction of extrusion has important consequences
for the extruded cell’s fate. As most cells extrude apically,
they are typically eliminated through the lumen; however, cells
with upregulated survival signals that extrude basally could
potentially invade the underlying tissue and migrate to other
sites in the body.
Results: We found that oncogenic K-Ras cells predominantly
extrude basally, rather than apically, in a cell-autonomous
manner and can survive and proliferate after extrusion.
Expression of K-RasV12 downregulates the bioactive lipid
sphingosine 1-phosphate (S1P) and its receptor S1P2, both
of which are required for apical extrusion. Surprisingly, the
S1P biosynthetic pathway is not affected because the S1P
precursor, sphingosine kinase, and the degradative enzymes
S1P lyase and S1PP phosphatase are not significantly altered.
Instead, we found that high levels of autophagy in extruding
RasV12 cells leads to S1P degradation. Disruption of auto-
phagy chemically or genetically in K-RasV12 cells rescues
S1P localization and apical extrusion.
Conclusions: Oncogenic K-Ras cells downregulate both S1P
and its receptor S1P2 to promote basal extrusion. Because live
basally extruding cells can survive and proliferate after extru-
sion, we propose that basal cell extrusion provides a novel
mechanism for cells to exit the epithelium and initiate invasion
into the surrounding tissues.
Introduction
Epithelia provide a protective barrier for the organs they
encase, yet the cells comprising epithelia are constantly
turning over via cell death and cell division. Tomaintain a func-
tional barrier, cells destined to die are squeezed out of the
epithelium by a mechanism that we have termed ‘‘cell extru-
sion’’ [1]. In previous work, we have shown that this process
is mediated by the bioactive sphingolipid, sphingosine
1-phosphate (S1P), which is produced by the extruding cell
and binds to a G protein-coupled receptor (S1P2) in the neigh-
boring cells to trigger the guanosine triphosphatase (GTPase)
Rho to form and contract an intercellular actomyosin band [2].
This contraction squeezes the cell out of the epithelial sheet
while simultaneously closing the gap that may have resulted
from the cell’s exit, thus preserving the epithelial barrier
function.
Although extrusion is activated whenever cells are targeted
to die by apoptotic stimuli, we have found that normally during
homeostasis, extrusion drives cell death [3, 4]. Tomaintain cell
number homeostasis, epithelia extrude live cells at sites where
epithelial cells are most crowded both in vivo and in vitro. Live
extruded cells generally die by anoikis, a type of cell death
caused by the loss of survival signals from cell matrix [5].
Blocking extrusion leads to epithelial cell masses, supporting
the idea that cell extrusion promotes death. On the other hand,
metastatic tumor cells upregulate survival signaling, which can
override anoikis and enable survival after extrusion [6–8].
Should cells survive after extrusion, the direction they
extrude could have important consequences for their fate.
Typically, epithelia extrude cells apically into the lumen, so
that even transformed live cells would be eliminated into
essentially dead space. Less frequently, however, cells can
extrude basally into the tissue the epithelium encases. Should
transformed cells that can no longer die extrude basally, they
may have the potential to invade the underlying tissue and
initiate metastasis. The direction a cell extrudes depends on
if the actomyosin ring formed in its neighboring cells contracts
along the basolateral cell surface or at the apex to push the cell
out above or below the epithelium, respectively [9, 10]. Where
the actomyosin ring contracts depends, at least in part, upon
microtubule dynamics and the tumor suppressor adenoma-
tous polyposis coli (APC), which target where the ring forms
[9, 10].
To investigate the fate of extruded cells that upregulate sur-
vival signals and override anoikis, we expressed a commonly
occurring oncogenic allele of K-Ras (K-RasV12), which renders
it constitutively active, leading to downregulation of apoptosis
and increased cell survival. Increased survival in K-Ras-
transformed cells is thought to be from not only increased
expression of survival signals but also enhanced protective
autophagy [11–14]. The importance of mutations in the
K-RAS proto-oncogene is well established in epithelial-based
carcinogenesis, especially in lung, pancreatic, and colon
carcinomas.
Here, we investigated if cells expressing oncogenic K-Ras
could still extrude, and if so, could they survive after extrusion.
We found that K-RasV12 cells not only survive and proliferate
after extrusion but, surprisingly, also preferentially extrude
basally, beneath epithelia. Moreover, we found that K-RasV12
cell basal extrusion is cell autonomous. Interestingly, we found
that high levels of autophagy in extruding oncogenic K-Ras
cells disrupt S1P production and signaling required for apical
extrusion. S1P normally forms puncta at the interface between
an apically extruding cell and its neighboring cells and is
required only for apical but not basal extrusion. In extruding
oncogenic K-Ras cells, however, S1P is greatly decreased
despite the fact that the pathways required for its synthesis
and degradation are unaltered.We found that markers of auto-
phagy, typically upregulated in oncogenic K-Ras cells, are
even more pronounced in extruding K-Ras cells. Blocking*Correspondence: jody.rosenblatt@hci.utah.edu
28
autophagy rescues S1P localization and apical extrusion.
Thus, K-Ras transformation can promote basal extrusion and
enable cells with higher survival and proliferation potential to
exit the epithelia and initiate invasion.
Results
Epithelial Cells Expressing K-RasV12 Extrude Basally
in a Cell-Autonomous Manner
Because we previously found that epithelia normally extrude
cells that later die due to loss of survival signaling, or anoikis,
we wondered if transformed cells that block anoikis could
still extrude and survive after extrusion. To test this hypothe-
sis, we expressed oncogenic K-Ras, which upregulates sur-
vival signals that override anoikis. To determine whether cells
expressing oncogenic K-Ras can still extrude, we induced
extrusion in Madin-Darby canine kidney (MDCK) II cell mono-
layers that stably express either yellow fluorescent protein
(YFP)-tagged K-RasWT or GFP-tagged K-RasV12 by irradiating
with UV254 to induce apoptosis. Surprisingly, we found that
GFP-K-RasV12-expressing cells extrude predominantly
(w75%) basally rather than apically, the direction typically
seen in wild-type (WT) MDCK monolayers or MDCK cells
expressing WT K-Ras (Figures 1A–1C and quantified in Fig-
ure 1D). To demonstrate the direction a cell extrudes in a sin-
gle picture, we overlaid the xy plane of the actin-extruding
ring with the xy plane of the DNA of the extruded cell.
Thus, during apical extrusion in WT and YFP-K-RasWT, the
apoptotic nucleus lies above the plane of the actin ring so
that the nuclei of the surrounding cells are not in focus
(also see xz insets in Figures 1A and 1B and schematics
below). GFP-K-RasV12 basally extruding cells, conversely,
contract an actin ring apically above the apoptotic nucleus,
which lies in the same xy plane as the nuclei of the surround-
ing cells (Figure 1C, xz insets, schematic below; Movie S1
available online). Although these extruding cells did not sur-
vive such harsh apoptotic stimulus, we found that cells
extruding without apoptotic stimulus from overgrown mono-
layers also did so predominantly basally (Figure S1).
To determine if K-RasV12 expression controls basal extru-
sion within the extruding cell or the cells neighboring it, we
induced extrusion by UV-irradiating monolayers comprised
of a 1:100 ratio of GFP-K-RasV12 to WT MDCK cells. GFP-
K-RasV12 expression in the extruding cell was sufficient to
drive extrusion basally at rates similar to homogeneously ex-
pressed GFP-K-RasV12 (Figure 1E, with quantification in Fig-
ure 1F; Movie S2). Thus, K-RasV12 drives basal extrusion
cell autonomously, suggesting that tumor cells in which
this mutation arises could use basal extrusion to invade
beneath the epithelium. Alternatively, cells could be induced

















   
   
   






















































Figure 1. Epithelial Cells Expressing K-RasV12 Extrude Basally in a Cell-Autonomous Manner
(A–C) Confocal projections and xz cross-sections (below) showing extruding cells (white arrowheads). Control MDCK cells (A) and those expressing YFP-
K-RasWT (B) extrude apically (DNA of extruding cell is out of planewith neighboring cells), whereas those expressing GFP-K-RasV12 (C) extrude basally (DNA
of extruding cell is in same plane as neighboring cells).
(D) Quantification of cell extrusion events from five independent experiments with >1,000 extruding cells per cell line.
(E) MDCK GFP-K-RasV12 cells mixed with WT MDCK cells 1:100 indicate that K-RasV12 cells (green arrow) drive basal extrusion cell autonomously, where
arrowhead indicates basally extruded K-RasV12 cell, and asterisks show WT cells. Pink and blue arrows indicate actin ring and DNA, respectively, and
dashed line where the xz section was taken.
(F) Quantification of three independent experiments, where n = 600 extruding cells.
Scale bars represent 10 mm. Error bars indicate the SEM. p < 0.001 by Student’s t test comparing control to RasV12. See also Figure S1 and Movies S1
and S2.
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S1P Signals Apical but Not Basal Extrusion and Is
Misregulated in K-RasV12-Expressing Cells
To determine how oncogenic K-Ras induces basal extrusion,
we investigated if the cytoskeletal mechanism or the
signaling controlling extrusion was altered in K-RasV12-
expressing monolayers. We previously found that the direc-
tion a cell extrudes depends upon where the actin and
myosin ring in the surrounding cells contracts [9, 10]. If it con-
tracts at the bottom of the cell, the cell exits apically, whereas
if it contracts apically, the cell extrudes basally. The site of
actomyosin ring contraction depends on microtubules
because altering microtubule dynamics with either taxol or
nocodazole or disruption of a protein that regulates microtu-
bules, APC, shifts the direction of extrusion from apical to
basal [9, 10]. Therefore, we examined if microtubules were
altered in K-RasV12-extruding cells. Unlike other situations
where the direction of extrusion was linked to misregulation
of microtubules, we found no obvious changes in microtu-
bules in K-RasV12-extruding cells or cells surrounding them
(Figures 2A and 2D). Next, we examined whether K-RasV12
expression could alter the intrinsic polarity of cells to alter
extrusion direction by immunostaining extruding monolayers
for ZO-1, an apical marker, and b-catenin, a component of
adherens-type junctions, used here as a basal marker. How-
ever, both of these polarity markers were also unaltered in
RasV12-compared to WT-extruding cells, suggesting that
K-RasV12 expression does not affect the direction of extru-
sion by disrupting the intrinsic polarity (Figures 2B–2F).
Therefore, we examined if K-RasV12 acted cell autonomously
to alter extrusion signaling.
A B C
D E F
Figure 2. K-RasV12 Does Not Affect Direction of Extrusion by Altering Microtubule Dynamics or Cell Intrinsic Polarity
Confocal projections and xz cross-sections (below) of control MDCKmonolayers apically extruding (A–C) and K-RasV12 monolayers basally extruding (D–F).
White arrows point to themicrotubules pointing basally during apical extrusion (A) and apically during basal extrusion (D), where asterisks indicate extruding
cells location. White arrows show the apical marker ZO-1 (B and E) and the basal marker b-catenin (Cat) (E and F) are both localized correctly. White arrow-
head indicates extruding cell, pink and blue arrows indicate actin ring and DNA, respectively, and dashed line where the xz section was taken. Scale bars
represent 10 mm.
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We next tested if extrusion signaling through S1P and the
S1P2 receptor were altered in oncogenic K-Ras-extruding
cells. We previously found that a cell destined to extrude emits
S1P, which binds the S1P2 receptor in neighboring cells to
activate Rho-mediated assembly and contraction of an inter-
cellular actomyosin ring that squeezes it out [1, 2]. Because
our previous data showed that disrupting S1P2 disrupts extru-
sion, we assessed S1P2 levels in K-Ras
V12 cells and found that
they hadw3-fold lower levels than WT MDCK cells by immu-
noblotting (Figure 3A). S1P is normally amplified only in
extruding cells; therefore, we immunostained for this lipid us-
ing a specific monoclonal antibody to S1P [2, 15] in extruding
monolayers. Whereas S1P forms prominent puncta at the
interface of extruding/neighboring cells along the basolateral
surface in control apically extruding cells (Figure 3B), S1P
was completely absent in basally extruding K-RasV12 cells
induced to extrude with UV (Figure 3E) or under homeostatic
conditions (Figure S1). By quantifying the number of extruding
cells that have S1P, we found that 89% of apically extruding
WT cells had S1P, whereas only 7% of K-RasV12 basally
extruding cells had S1P, where n = 100 for each cell type. In
the minor populations of K-RasV12 cells that extruded apically,
S1P was diffuse and mislocalized (Figure 3C). Importantly, the
minor population of control cells that basally extrudes also
lacked S1P puncta, suggesting that the S1P-S1P2 signaling
pathway signals apical but not basal extrusion (Figure 3D).
To test if the S1P pathway controls only apical and not basal






Figure 3. S1P and the S1P Receptor 2 Signal Apical but Not Basal Extrusion and Are Misregulated in K-RasV12-Expressing Cells
(A) Immunoblot analysis comparing the expression levels of S1P2 in control MDCK cells, and MDCK cells expressing K-Ras
WT or K-RasV12, where lamin B2
serves as a loading control, and quantified ratio compared to control is below.
(B–E) Confocal projections and xz cross-sections (below) showing an apically extruding control MDCK produces high S1P levels (B), whereas an apically
extruding K-RasV12 cell does not (C). Basally extruding control (D) and K-RasV12 (E) MDCK cells do not produce any S1P. White arrowheads point to dying,
extruding cells at live-dead cell interfaces, pink arrows indicate actin ring, blue arrows show DNA, and dashed line where the xz section was taken. Scale
bars represent 10 mm.
(F–G0) Apical extrusion is disrupted in control MDCK cells treated with S1P2 antagonist (JTE-013), where (F) shows comparative rates, and (G) shows total
rates from three independent experiments analyzing 300 extrusion events for each experiment. Error bars indicate the SEM. p < 0.001 by Student’s t test
comparing control versus each treatment. (G0) shows examples of blocked extrusion, scored by the presence of a faint actin ring that does not contract
around a late-staged caspase-3-positive dying cell, apical extrusion, and basal extrusion. Arrowheads show extruding cell.
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S1P2 antagonist, JTE-013. JTE-013 increased the percentage
of blocked extrusions, scored by the presence of a faint actin
ring that does not contract around a late-staged caspase-3-
positive dying cell, and seen previously in [2]. However, it
increased the relative percentage of basal extrusions (Fig-
ure 3F). Although blocking S1P2 signaling shifts the direction
of extrusion from apical to basal, it actually does so by block-
ing apical extrusion without affecting basal extrusion, as indi-
cated when total numbers of each type of extrusion were
quantified (Figure 3G). When total rates of apical versus basal
extrusion were similarly quantified in K-RasV12-extruding
monolayers, instead of relative percentages, we found that
they mirrored the effects of blocking S1P-S1P2 signaling
pathway on extrusion.
K-RasV12-Extruding Cells Express High Levels of the
Autophagy Marker LC3A/LC3B
To determine how S1P is downregulated in K-RasV12-
extruding cells, we analyzed the S1P synthetic pathway in
WT versus oncogenic K-Ras monolayers induced to extrude
with UV254. We found that sphingosine kinase 1 (SphK1), the
enzyme that converts sphingosine to S1P, was 1.5-fold upre-
gulated in K-RasV12-expressing cells (Figure 4A). Furthermore,
enzymes that downregulate S1P, by converting it back to
sphingosine or degrading it into phosphoethanolamine and
hexadecanal, S1P phosphatase 1 (S1PP), and S1P lyase,
respectively, were not significantly altered in K-RasV12 cells
(Figure 4A, where both are 0.9-fold that of WT cells). Immuno-
fluorescence also confirmed that S1P synthetic and degrada-
tive enzymes were not significantly altered in K-RasV12-
extruding cells compared to WT-extruding MDCK cells (data
not shown). Because neither S1P synthetic nor degradative
pathways were significantly altered in K-RasV12-expressing
cells, we next considered if S1P depletion in extruding





















































Figure 4. K-RasV12-Extruding Cells Express High
Levels of the Autophagy Marker LC3A/LC3B
(A) SIP synthetic pathway and immunoblots
comparing the expression levels of key regula-
tors of S1P in control versus K-RasV12 cell lysates
where tubulin and lamin serve as loading
controls.
(B) LC3A/LC3B immunoblots of MDCK, K-RasWT,
and K-RasV12 cells, where a-tubulin serves as a
loading control, LC3A/LC3B-I is the cytosolic
form, whereas LC3A/LC3B-II is associated with
autophagosomes. Ratios compared to the con-
trol are below.
(C) Confocal projections of control MDCK cells
and K-RasV12 basal-extruding cell; white arrow-
heads show increased LC3 puncta in extruding
cell. Scale bars represent 10 mm.
See also Figure S2 and Movies S3 and S4.
Because other studies have found
that both oncogenic K-Ras expression
[11–14] and SK1 levels [16] can promote
autophagy, we investigated if auto-
phagy may act to degrade S1P during
K-RasV12 cell extrusion. Autophagy is
a process of cellular degradation
where components of the cytoplasm
and organelles are sequestered into au-
tophagosomes, which then fuse with
lysosomes to become degraded. Although cells use auto-
phagy to conserve energy and resources during starvation,
oncogenic Ras cells have been found to be addicted to auto-
phagy to increase their survival rates [11–14]. Although auto-
phagy has not been previously reported to degrade S1P, the
fact that other membranous compartments of the cell can be
degraded by autophagy suggests that S1P could also be
degraded in this way. Additionally, because several sphingoli-
pids have been found to promote autophagy [17, 18], it
seemed possible that a sphingolipid also could be regulated
by autophagy. Autophagosomes form by converting the auto-
phagymarkerMicrotubule-Associated Protein 1-Light-Chain 3
(LC3) forms A and B from a cytosolic form (LC3-I) to a phos-
phatidylethanolamine-conjugated membrane-bound form
(LC3-II). Thus, autophagic activity can be identified by LC3
puncta formation using immunofluorescence and LC3-II by a
shift in itsmigration on immunoblots [19]. Using bothmethods,
we found that compared to control cells, K-RasV12 cells had
elevated levels of the autophagy marker LC3-II (Figure 4B).
LC3A/LC3B was even more enriched in K-RasV12-extruding
cells compared to neighboring K-RasV12 cells when viewed
by immunofluorescence (Figure 4C). Quantification of LC3A/
LC3B fluorescent intensity showed that K-RasV12-extruding
cells had consistently higher numbers of puncta (w2,300
mean fluorescent intensity per 20 cells) compared to their non-
extruding neighboring cells (w800 mean fluorescent intensity
per 20 cells). The LC3A/LC3B increase in extruding cells may
be similar to that seen in extruding cells in Drosophila amnio-
serosa prior to extrusion [20]. Extruding K-RasV12 may have
higher levels of autophagy than either WT-extruding or unex-
truding K-RasV12 cells due to the fact that both K-RasV12
signaling and extrusion signaling promote autophagy (as
seen in Figure 4B). Our findings that autophagy is especially
prominent in K-RasV12 cells targeted to extrude suggests a
mechanism for how these cells downregulate S1P to promote
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basal extrusion. To determine if inducing autophagy in control
MDCK cells alone could switch the direction of extrusion from
predominantly apical to basal, we treated MDCK monolayers
with Torin-2 (a potent ATP-competitive inhibitor of mammalian
target of rapamycin [mTOR]) that induces autophagy. We
found that inducing autophagy in otherwise WT cells was
sufficient to cause cells to extrude basally (Figure S2).
Blocking Autophagy in K-RasV12 Cells Rescues S1P
Localization and Apical Extrusion
To test if the increased autophagy in K-RasV12 cells disrupts
S1P-mediated apical extrusion, we blocked autophagy to
assess if it would rescue both S1P and apical extrusion. We
pretreated control and K-RasV12 monolayers with commonly
used small molecule inhibitors of autophagy, induced extru-
sion, and assayed for both S1P expression (Figures 5A and
5B) and the direction cells extrude (Figure 5C). By blocking
autophagy with the phosphoinositide-3 kinase inhibitor wort-
mannin, which blocks autophagosome formation [21], or with
bafilomycin A1 [22] or chloroquine [23], which both block auto-
phagosome degradation by preventing fusion with the lyso-
some, we found that inhibition of autophagy increased the
percentage of cells undergoing apical extrusion compared to
untreated K-RasV12 cells (Figures 5A and 5B and quantified
in Figure 5C). We expressed the tandem mCherry-EGFP-
LC3B reporter in oncogenic K-Ras cells to confirm that auto-
phagic flux to the lysosome was occurring in basally extruding
cells. This reporter indicated that LC3 becomes targeted to
lysosomes, inactivating GFP and turning red when a
K-RasV12 cell extrudes basally (Movie S3; Figure S3A) but stays
yellow when fusion to the lysosome is blocked with chloro-
quine and the cell extrudes apically (Movie S4; Figure S3B).
Moreover, the treatments rescuedS1P expression in extruding
K-RasV12 cells (Figure 5B). On the other hand, blocking auto-
phagy did not affect S1P2 receptor levels, as measured by
immunoblotting or immunostaining (Figure S4), suggesting
that enough S1P2 remains in the K-Ras
V12 to rescue apical
extrusion if S1P levels are increased.
Because these inhibitors can also affect other cellular func-
tions, we confirmed if blocking autophagy could rescue S1P
accumulation and apical extrusion in K-RasV12 by knocking
down two essential autophagy genes: Atg7 and Atg5. Simi-
larly, Atg7 or Atg5 knockdown rescued both S1P puncta
formation (Figure 5E) and apical extrusion (Figure 5F) in
K-RasV12-extruding cells (Figure S5). The decrease in auto-
phagy flux by diminished expression of LC3-II and accumula-
tion of the p62/SQSTM1-scaffolding protein that is degraded
by autophagy confirmed that Atg knockdown blocked auto-
phagy (Figures 5D and S5). Therefore, K-RasV12 cells drive
cells to extrude basally by targeting the proextrusion signal
S1P for degradation, and both S1P and apical extrusion can
be rescued by simply blocking autophagy.
Although these experiments yielded the surprising finding
that oncogenic K-Ras drives extrusion basally rather than
apically, theywere not able to assesswhether basally extruded
cells could survive and proliferate after extrusion for several
reasons. First, to increase the rates of extrusion, we typically
induce extrusion with the strong apoptotic stimulus, UV254,
which makes the extruding cells apoptotic. Although
K-RasV12 cells extruding during homeostasis (without UV treat-
ment) extrude predominantly basally (Figure S1) and WT cells
extrude predominantly apically at the same ratios as when
apoptosis is induced, the extrusion rates are greatly reduced,
making them harder to score. Second, if we allow cells to
naturally extrude and accumulate over time, it is extremely
hard to identify quantifiable numbers of live extruded cells in
two-dimensional (2D) cultures: live apically extruded cells are
lost within the medium, and live basally extruded cells may
intercalate into the normal surrounding cells within the mono-
layer. Moreover, live basally extruded K-RasV12 cells would be
far more likely to die after basal extrusion in cell culture than in
real tissue because they could become trapped between the
cover glass and the monolayer, which would prevent their
access to growth factors. In vivo, live basally extruded cells
might still have access to growth factors in the matrix and un-
derlying stroma. Therefore, we decided to investigate the fate
of basally extruded cells in 3D cultures.
Basally Extruded K-RasV12 Cells Survive and Proliferate
in 3D Cultures
To test if GFP-K-RasV12 cells can survive after extrusion, we
grew control and K-RasV12-expressingMDCKcells as 3D cysts
[24], where we would be able to score viability after extrusion.
MDCK cells grown in Matrigel form a clonal acinar structure
containing a hollow lumen that faces the apical surface (Fig-
ure 6A). Cysts comprised of oncogenic K-Ras MDCK cells,
however, extruded live cells that persisted and often divided
(Figure 6B). Eventually, these K-RasV12 cells developed
lumens filled with apoptotic cells, live cells, and smaller cysts,
similar to results found with ErbB2 expression [25] (Figure S6).
Additionally, approximately 20%of K-RasV12 MDCK cysts also
formed mini cysts attached to the outside of the main cyst
(Figure 6C).
To determine the frequency of survival of the basally
extruded K-RasV12 compared to WT control cells, and those
expressing WT K-Ras in 3D cultures, we immunostained cysts
grown under homeostatic conditions for 3 days for the
apoptotic marker antiactive caspase-3. We found that 67%
of K-RasV12 cells extrude live cells, whereas WT MDCK cells
or MDCK cells expressing WT K-Ras only extrude 2% live
cells, where the remainder are apoptotic (Figure S6). Attached
basal mini cysts could arise either from other live migrating
cells attaching to cysts or from proliferation of live basally
extruded cells to form new smaller cysts. To test between
these two models, we imaged live-cell extrusion by phase
time-lapse video microscopy of control MDCK or GFP-K-
RasV12 cysts grown under homeostatic conditions. Whereas
cells from MDCK cysts extruded into the lumen, underwent
apoptosis, and were engulfed by neighboring cells (Figure 6D;
Movie S5, left), apically extruded K-RasV12 cells were not en-
gulfed and instead filled the cyst’s lumen. Furthermore, basally
extruded K-RasV12 cells either migrated away from the cyst or
proliferated into a mini cyst (Figure 6E; Movie S5, right). Onco-
genic K-Ras cells expressing fluorescently tagged myosin
light chain (MLC) or actin clearly show that cells escaping
the cyst do so by extrusion, as characterized by contraction
of an actin and myosin II ring (Figure 6F; Movie S6). These
data indicate that K-RasV12 cells under homeostatic conditions
extrude basally and, instead of dying, proliferate, suggesting
that basal extrusion could provide a mechanism for invading
matrix and tissue underlying epithelia.
Discussion
We have found that epithelial cells stably expressing onco-
genic K-Ras extrude predominantly basally from both epithe-
lial monolayers and 3D cysts in culture. Basal extrusion is
cell autonomous because single K-RasV12 cells surrounded

















Figure 5. Blocking Autophagy in K-RasV12 Cells Rescues S1P Localization and Apical Extrusion
(A and B) Confocal section and xz cross-sections (below) of a K-RasV12monolayer that extrudes primarily basally and lacks SIP (A) but extrudes apically and
accumulates S1P puncta with 30 mM chloroquine, which blocks autophagy (B), where white arrowheads indicate extruding cells at the live-dead cell inter-
faces, pink arrows indicate actin ring, blue arrows show DNA, and dashed line the xz section. Scale bars represent 10 mm.
(C) Quantifications of cell extrusion directionwith three autophagy inhibitors from four independent experiments where >1,000 extrusionswere analyzed per
treatment. Error bars indicate the SEM.
(D) Immunoblots show siRNA-mediated knockdown of Atg7 and LC3-II reduction and p62 upregulation. Ratios compared to the control (Ctr.) are below.
Atg7 knockdown also rescues apical extrusion and S1P. Tub, tubulin.
(E and F) Quantification from <500 total extrusion events from three siRNA experiments. p < 0.001 by Student’s t test comparing control versus each treat-
ment. The scale bar represents 10 mm.
(G) Model for how apical extrusion is misregulated in K-RasV12-expressing cells. S1P normally binds S1P2 in surrounding cells to contract basally and
squeeze the cell out. However, in K-RasV12-extruding cells, S1P is targeted for degradation by increased autophagy. Without S1P, basolateral contraction
in neighboring cells is not activated, and instead, only apical contraction of the dying cell occurs, driving extrusion basally. S1P (blue), autophagosome
(yellow), lysosome (green), extruding cell actomyosin contraction (red), and neighboring cell actomyosin contraction (maroon). KD, knockdown.
See also Figures S3–S5.
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byWT cells also drive extrusion basally. Importantly, we found
that although oncogenic K-Ras cells are typically autophagic,
autophagy is even higher when these cells extrude, which dis-
rupts S1P critical for apical extrusion. The normal S1P synthe-
sis pathway is not altered in K-RasV12 cells, however, because
blocking autophagy either by knockdown of Atg5 or Atg7 or by
chemical inhibitors rescues S1P puncta formation and apical
extrusion. Together, our results suggest a model where
K-RasV12 cells targeted for normal extrusion produce S1P,
which due to high levels of autophagy, becomes degraded in
the lysosomes (Figure 5G). When S1P is absent, it can no
longer signal neighboring cells to contract basally and extrude
the cell apically. Instead, the basally extruding K-RasV12 cell
contracts at the apical junctions where actin and myosin II
already exist, driving the cell out basally. In WT cells or when
autophagy is blocked, S1P produced in the cell targeted for
extrusion activates S1P2 in the neighboring cells to contract
basally and shove the cell out apically.
Although we previously identified that extrusion requires the
S1P-S1P2-Rho pathway, here, we find that this signaling axis
controls only apical but not basal extrusion. This was not
directly apparent because most cells extrude apically. Our
finding that K-RasV12 cells switch the extrusion direction
from apical to basal by degrading S1P and downregulating
S1P2 also demonstrated that S1P signaling is only required
for apical extrusion. Rescuing S1P by blocking autophagy res-
cues apical extrusion in K-RasV12 cells. K-RasV12 cells may
affect extrusion also by downregulating the S1P2 receptor by
an autophagy-independent mechanism. However, the fact
that blocking autophagy is sufficient to rescue apical extrusion
suggests that there is enough S1P2 present in K-Ras-trans-
formed cells to enable apical extrusion when S1P levels are
restored.
Our results showing that oncogenic K-Ras cells extrude
basally contrast somewhat to those found by Hogan et al.
that show H-Ras transformation causes apical extrusion [26].
We believe that the main difference in our results lies in the
length of time K-RasV12 is expressed. In experiments like
ours where K-RasV12 is expressed constitutively, Liu et al.
found that a single oncogenic H-Ras cell within a cyst either
extruded basally or migrated [27], suggesting that basal
extrusion may be a common feature of expressing any form
of oncogenic Ras long term. Hogan et al. [26], instead, use
an inducible expression system to activate H-RasV12 acutely.
Acute H-RasV12 causes cells that divide to segregate from their
surroundingWT cells within the monolayer by what appears to
be differential adhesion, rather than the extrusion process we
have defined [26]. We have found similar results if we express
K-RasV12 acutely (data not shown), suggesting that expressing
any isoform of activated Ras transiently will cause delamina-
tion apically. Although the ultimate effect is the same—that
these cells delaminate from the epithelium—they do not do
so through the canonical extrusion pathway that requires






Figure 6. Basally Extruded K-RasV12 Cells Survive and Proliferate in 3D Cultures
(A and B) Cysts from MDCK and K-RasV12-MDCK cells cultured in Matrigel for 3 days. Confocal sections show that WT MDCK cysts have clear lumens (A),
whereas MDCK K-RasV12 cysts extrude live cells basally (B). Yellow arrowhead, filled lumen; red arrows, live basal extruded cells.
(C) Quantification of phenotypes over time from three independent experiments (n > 100 cysts per experiment). Error bars indicate the SEM. p < 0.001 by
Student’s t test comparing control to RasV12.
(D and E) Stills frommovies of cysts (in Movie S5) filmed at day 3 for 24 hr without UV treatment. A control MDCK cyst extrudes cells apically into the lumen
(yellow arrow) (D), whereas a K-RasV12 cyst extrudes cells basally into the matrix, which later proliferate (E) (red arrows).
(F) Stills from amovie of a UV-treated K-RasV12 cyst expressingMLC-red fluorescent protein (RFP) (inMovie S6) show that basal extrusion of a cell occurs by
contraction of a myosin ring.
Scale bars represent 20 mm. Time is indicated as hr:min. See also Figure S6 and Movies S5 and S6.
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that contracts in surrounding cells. Therefore, alternative
downstream signaling may lead to apical delamination versus
basal extrusion depending on the length of oncogenic K-Ras
signaling.
Although we focused mainly on the mechanism that drives
K-RasV12 epithelial cells to extrude basally when targeted for
cell death, it is important to note that live cells also extrude
basally when no apoptotic stimulus is present. Because most
cells extrude live prior to dying, the direction live cells extrude
has important consequences for their later fate. Apically
extruded cells will essentially be eliminated through the lumen
or outside the body, even if transformed by K-RasV12, whereas
basally extruded transformed cells could potentially invade
and initiate metastasis. Thus, apical elimination of cells that
become mutated with K-RasV12 could act as a self-regulating
mechanism to rid the body of transformed precancerous cells.
On the other hand, oncogenic K-Ras-driven tumors, such as
lung or pancreatic carcinomas, serve as testament to the fact
that this mechanism sometimes fails. In these cases, shifting
extrusion from apical to basal coupled with increased cell sur-
vival could act to promote tumor progression and metastasis.
This newly defined potential mechanism for invasion, which is
enhanced specifically in K-Ras-transformed cells, could
explain why K-Ras-driven tumors are so metastatic and
deadly. Our results suggest that simply blocking autophagy
with chloroquine, a drug already in clinical use [28, 29], could
prevent invasion of K-RasV12-driven tumors and better target
them for apoptosis. Therefore, future studies will need to
determine if basal extrusion of K-Ras cells can promote their
invasion and metastasis in vivo and, if so, whether inhibition
of autophagy can reverse this invasive phenotype.
Experimental Procedures
Cell Culture
Control MDCK II cells and cells expressing oncogenic K-Ras (gift from
K. Matlin, University of Chicago, Chicago, IL) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) high glucose with 5% FBS (all from
HyClone) and 100 mg/ml penicillin/streptomycin (Invitrogen) at 5% CO2,
37C. MDCK II cells stably expressing GFP-oncogenic or YFP-WT K-Ras
were generated by transfecting pEGFP C3 containing K-RasV12 or pEYFP
C1 containing K-RasWT (gift from Channing J. Der, University of North
Carolina, Chapel Hill, NC), respectively, by using Lipofectamine 2000 (Invi-
trogen) according to manufacturer’s instructions. To monitor autophagy
flux in oncogenic K-Ras cells, we nucleofected cells (according to themanu-
facturer Lonza Biologics) with pBABE-puro mCherry-EGFP-LC3B tandem
biosensor (Addgene plasmid 22418 deposited by Jayanta Debnath).
MDCK cysts were generated as previously described in [24] and the
Supplemental Experimental Procedures. For live fluorescent imaging of
MLC (gift from Thomas Marshall, University of Utah, Salt Lake City, UT) or
mApple-actin-7 (a gift from Michael W. Davidson, Florida State University,
Tallahassee, FL), oncogenic K-Ras cells were transduced or transfected,
respectively, before culturing in Matrigel.
UV and Drug Treatment
MDCK II cells grown to confluence on glass coverslips were exposed to
1,200 uJ/cm2 UV254 for 43 s using a Spectrolinker (Spectroline) to induce
apoptotic extrusion and incubated for 2 hr before fixation. For complete cell
drug treatment, please refer to the Supplemental Experimental Procedures.
Cell Staining
Cells were either fixed with ice-cold 100%methanol for 45 s or 4% parafor-
maldehyde in PBS at 37C for 20 min. For protocols and antibodies, please
refer to the Supplemental Experimental Procedures.
RNAi
siRNAs against the canine ATG7 and ATG5 sequences were synthesized at
the University of Utah Oligo and Peptide Synthesis Core. For complete se-
quences, refer to the Supplemental Experimental Procedures.
Image, Video Acquisition, and Immunoblot Analysis
Microscopy and immunoblots were performed according to standard pro-
tocols. For details, please see the Supplemental Experimental Procedures.
Statistical Analysis
All statistical analyses were performed using Prism 5 (GraphPad) and
employing unpaired t test.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, six figures, and six movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.11.029.
Acknowledgments
We thank Katie Ullman and Thomas Marshall for helpful comments on our
manuscript. We also thank Karl Matlin for his MDCK cell lines and Jayanta
Debnath for first suggesting that we investigate autophagy. This work was
supported by a National Institute of Health Innovator Award numbers DP2
OD002056-01 and 1R01GM102169-01 to J.R., a NIH Developmental Biology
Training Grant 5T32 HDO7491 to G.S., and P30 CA042014 awarded to the
Huntsman Cancer Institute for core facilities. R.A.S. has stock options in
Lpath, Inc.
Received: January 11, 2013
Revised: October 11, 2013
Accepted: November 14, 2013
Published: December 19, 2013
References
1. Rosenblatt, J., Raff, M.C., and Cramer, L.P. (2001). An epithelial cell
destined for apoptosis signals its neighbors to extrude it by an actin-
and myosin-dependent mechanism. Curr. Biol. 11, 1847–1857.
2. Gu, Y., Forostyan, T., Sabbadini, R., and Rosenblatt, J. (2011). Epithelial
cell extrusion requires the sphingosine-1-phosphate receptor 2
pathway. J. Cell Biol. 193, 667–676.
3. Eisenhoffer, G.T., Loftus, P.D., Yoshigi, M., Otsuna, H., Chien, C.B.,
Morcos, P.A., and Rosenblatt, J. (2012). Crowding induces live cell
extrusion to maintain homeostatic cell numbers in epithelia. Nature
484, 546–549.
4. Marinari, E., Mehonic, A., Curran, S., Gale, J., Duke, T., and Baum, B.
(2012). Live-cell delamination counterbalances epithelial growth to limit
tissue overcrowding. Nature 484, 542–545.
5. Frisch, S.M., Vuori, K., Ruoslahti, E., and Chan-Hui, P.Y. (1996). Control
of adhesion-dependent cell survival by focal adhesion kinase. J. Cell
Biol. 134, 793–799.
6. Douma, S., Van Laar, T., Zevenhoven, J., Meuwissen, R., Van Garderen,
E., and Peeper, D.S. (2004). Suppression of anoikis and induction of
metastasis by the neurotrophic receptor TrkB. Nature 430, 1034–1039.
7. Horbinski, C., Mojesky, C., and Kyprianou, N. (2010). Live free or die:
tales of homeless (cells) in cancer. Am. J. Pathol. 177, 1044–1052.
8. Taddei, M.L., Giannoni, E., Fiaschi, T., and Chiarugi, P. (2012). Anoikis:
an emerging hallmark in health and diseases. J. Pathol. 226, 380–393.
9. Marshall, T.W., Lloyd, I.E., Delalande, J.M., Na¨thke, I., andRosenblatt, J.
(2011). The tumor suppressor adenomatous polyposis coli controls the
direction in which a cell extrudes from an epithelium. Mol. Biol. Cell 22,
3962–3970.
10. Slattum, G., McGee, K.M., and Rosenblatt, J. (2009). P115 RhoGEF and
microtubules decide the direction apoptotic cells extrude from an
epithelium. J. Cell Biol. 186, 693–702.
11. Mathew, R., and White, E. (2011). Autophagy, stress, and cancer meta-
bolism: what doesn’t kill you makes you stronger. Cold Spring Harb.
Symp. Quant. Biol. 76, 389–396.
12. Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-
Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V.,
et al. (2011). Activated Ras requires autophagy to maintain oxidative
metabolism and tumorigenesis. Genes Dev. 25, 460–470.
13. Mirzoeva, O.K., Hann, B., Hom, Y.K., Debnath, J., Aftab, D., Shokat, K.,
and Korn, W.M. (2011). Autophagy suppression promotes apoptotic cell
death in response to inhibition of the PI3K-mTOR pathway in pancreatic
adenocarcinoma. J. Mol. Med. 89, 877–889.
Oncogenic K-Ras Drives Epithelial Basal Extrusion
27
36
14. Lock, R., and Debnath, J. (2011). Ras, autophagy and glycolysis. Cell
Cycle 10, 1516–1517.
15. Swaney, J.S., Moreno, K.M., Gentile, A.M., Sabbadini, R.A., and Stoller,
G.L. (2008). Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator
in the eye. Exp. Eye Res. 87, 367–375.
16. Lavieu, G., Scarlatti, F., Sala, G., Carpentier, S., Levade, T., Ghidoni, R.,
Botti, J., and Codogno, P. (2006). Regulation of autophagy by sphingo-
sine kinase 1 and its role in cell survival during nutrient starvation.
J. Biol. Chem. 281, 8518–8527.
17. Young, M.M., Kester, M., and Wang, H.G. (2013). Sphingolipids: regula-
tors of crosstalk between apoptosis and autophagy. J. Lipid Res. 54,
5–19.
18. Bedia, C., Levade, T., and Codogno, P. (2011). Regulation of autophagy
by sphingolipids. Anticancer. Agents Med. Chem. 11, 844–853.
19. Tanida, I., Ueno, T., and Kominami, E. (2008). LC3 and autophagy.
Methods Mol. Biol. 445, 77–88.
20. Cormier, O., Mohseni, N., Voytyuk, I., and Reed, B.H. (2012). Autophagy
can promote but is not required for epithelial cell extrusion in the amnio-
serosa of the Drosophila embryo. Autophagy 8, 252–264.
21. Blommaart, E.F., Krause, U., Schellens, J.P., Vreeling-Sindela´rova´, H.,
and Meijer, A.J. (1997). The phosphatidylinositol 3-kinase inhibitors
wortmannin and LY294002 inhibit autophagy in isolated rat hepato-
cytes. Eur. J. Biochem. 243, 240–246.
22. Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., and Tashiro, Y.
(1991). Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-
ATPase, inhibits acidification and protein degradation in lysosomes of
cultured cells. J. Biol. Chem. 266, 17707–17712.
23. Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D.,
Tuschl, T., and Mu¨nz, C. (2005). Endogenous MHC class II processing
of a viral nuclear antigen after autophagy. Science 307, 593–596.
24. Zegers, M.M., O’Brien, L.E., Yu, W., Datta, A., and Mostov, K.E. (2003).
Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol. 13,
169–176.
25. Leung, C.T., and Brugge, J.S. (2012). Outgrowth of single oncogene-
expressing cells from suppressive epithelial environments. Nature
482, 410–413.
26. Hogan, C., Dupre´-Crochet, S., Norman, M., Kajita, M., Zimmermann, C.,
Pelling, A.E., Piddini, E., Baena-Lo´pez, L.A., Vincent, J.P., Itoh, Y., et al.
(2009). Characterization of the interface between normal and trans-
formed epithelial cells. Nat. Cell Biol. 11, 460–467.
27. Liu, J.S., Farlow, J.T., Paulson, A.K., Labarge, M.A., and Gartner, Z.J.
(2012). Programmed cell-to-cell variability in Ras activity triggers emer-
gent behaviors during mammary epithelial morphogenesis. Cell Rep 2,
1461–1470.
28. Krishna, S., andWhite, N.J. (1996). Pharmacokinetics of quinine, chloro-
quine and amodiaquine. Clinical implications. Clin. Pharmacokinet. 30,
263–299.
29. Solomon, V.R., and Lee, H. (2009). Chloroquine and its analogs: a new
promise of an old drug for effective and safe cancer therapies. Eur. J.
Pharmacol. 625, 220–233.
Current Biology Vol 24 No 1
28
37
Current Biology, Volume 24
Supplemental Information
Autophagy in Oncogenic K-Ras 
Promotes Basal Extrusion 
of Epithelial Cells by Degrading S1P 






   



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Experimental Procedures  
Cell Culture 
MDCKs cysts were generated by a single cell suspension of MDCK II cells resuspended 
in Growth Factor Reduced Matrigel (BD Biosciences) to a final concentration 4% and 
placed in 8 well coverglass chambers (Nalge Nunc) coated with a thin polymerized layer 
of Matrigel. For live imaging cells were placed on 24 well glass-bottom culture dishes 
(MatTeK Corporation). After 20 min incubation at 37°C, cell-growth medium was added 
on top. Cysts were allowed to grow for the indicated duration and analyzed by time-lapse 
imaging or fixed with 4% paraformaldehyde.   
 
UV and Drug treatment 
To prevent photobleaching over the long time periods require to catch a live basal 
extrusion in 3D, for fluorescent live imaging, we treated cyst with 1200 uJ/cm2 UV254 
using a Spectrolinker (Spectroline) for 43 seconds to induce apoptotic extrusion. For 2D 
cultures, MDCK II cells grown to confluence on glass coverslips were exposed to 1200 
uJ/cm2 UV254 for 43 seconds to induce apoptotic extrusion and incubated for 2 h before 
fixation.  
Cells  were   treated  with   10  μM  JTE-013, 250nM of Torin-2      (Tocris  Bioscience),   1   μM  
Wortmannin, 10 nM Bafilomycin A1,  and  30  μM  Chloroquine  (all  from  Sigma-Aldrich) or 
1% DMSO as a control for 10 min before UV treatment.  
RNA Interference 
siRNAs against the canine ATG7 and ATG5 sequences were synthesized at the 
University of Utah Oligo and Peptide Synthesis Core to the following sequences: ATG7 
#1 AGAGAAAGCUGAAUGAGUA and ATG7#2 (GACCAAAGGACAAAGAUAA). ATG5 
#1 (5’-CAUUAGUGAGAUAUGGUUUGA-3’)   and   ATG5   #2   (5’-
AAACCAUAUCUCACUAAUGUC-3’)   annealed   in   100   mM   potassium   acetate,   30   mM  
Hepes-KOH, 2 mM magnesium acetate, pH 7.4, for 1 min at 90°C and 37°C for 1 h. 30 
pMol siRNAs were transfected by RNAimax reverse transfection according to the 
manufacturer’s  instructions  (Invitrogen).   
Cell staining 
Cells grown in 2-D, were either fixed with ice-cold 100% methanol for 45 sec (for LC3AB 
staining) or 4% paraformaldehyde in phosphate-buffered saline (PBS) at 37°C for 20 
min. Cells were then permeabilized with 0.5% Triton X-100 in PBS (PBS-T) for 5 min 
and blocked in AbDil (PBS with 0.1% Triton X-100 and 2% BSA) for 30 min. Primary 
antibodies: anti-active caspase-3 1:200 (BD Pharmingen), anti-S1P   50   μg/ml   (LPath  
Inc.), anti-actin 1:200 clone AC-74, anti-tubulin 1:200 (all from Sigma-Aldrich), anti-
LC3AB 1:100, anti--Catenin 1:100, anti-ZO-1 1:100 and anti LAMP1 1:200 (all from Cell 
Signaling) were applied in AbDil for 1 h or overnight (for 3-D cultures). After washing 
coverslips three times with PBS-T 0.1%, secondary antibodies Alexa Fluor-conjugated 
1:200, Alexa Fluor–conjugated  phalloidin  1:500  (all   from  Invitrogen),  and  DAPI  1  μg/ml  
(Sigma-Aldrich) to detect DNA were applied for 45 min. Following 3 washes with PBS-T 
0.1%, coverslips were mounted onto slides with Prolong Gold mounting media 
(Invitrogen). 
 
Image and video acquisition 
Imaging (confocal and live) was performed in a Nikon Eclipse TE300 inverted 
microscope converted for spinning disc confocal microscopy (Andor Technologies) using 
45
a 60X (for fixed samples) or 20X (for live imaging) Nikon Plan Apochromat lenses. 
Images were acquired with an electron-multiplied cooled charge-coupled device camera 
(DV887 1004X1002; Andor Technologies) driven by Andor IQ2 imaging software. For 
live imaging, temperature and CO2 were controlled by a Live Cell module (Pathology 
Devices) connected to the microscope. NIS Elements software (Nikon) and Image J 
were also used to analyze intensity of fluorescent for LC3AB and to quantify cell 
numbers. For quantification of extrusion, extruding cells were manually scored based on 
the presence of an actin ring and the apoptotic body localization with respect to the 
neighboring cells. Apoptotic cells that came out of the plane of the monolayer with strong 
actin staining around and/or underneath the cells were defined as apical extruded cells. 
Apoptotic cells remaining in the monolayer and underneath an apical ring were 
considered basally extruded cells. Cell survival following basal extrusion from cysts was 
defined by its lack of staining with active caspase-3 antibody. All images were processed 
further using Photoshop and Illustrator (Adobe), and QuickTime Pro (Apple) software. 
Immunoblot Analysis 
Whole-cell extracts were prepared by resuspending cells in NP40 Cell Lysis Buffer 
(Invitrogen) plus protease inhibitor cocktail (Roche). Proteins were resolved by SDS-
PAGE using NuPage gels (Invitrogen), and transferred to polyvinylidene difluoride 
membrane (Thermo). Membranes were probed with the following primary antibodies: 
anti-tubulin 1:1000 (Sigma- Aldrich), anti-LC3AB 1:1000, anti ATG5, and ATG7 1:1000  
(All from Cell Signaling), anti-sphingosine-1-phosphate phosphatase-1 1:500, anti p62 
(SQMT1) 1:500, anti Lamin B2 1:200  (All from Abcam), anti S1P2 1:500 (Imgenex), anti 
Sphingosine-1-phosphate Lyase-1 1:500 (Bioss), anti Sphingosine Kinase-1 1:1000 
(Cayman Chemical), and identified using horseradish peroxidase conjugated secondary 














5  CHAPTER 4
DEFECTIVE APICAL EXTRUSION SIGNALING CONTRIBUTES TO 
AGGRESIVE TUMOR HALLMARKS
Reprinted with permission from eLife. Gu Y, Shea J, Slattum G, Firpo MA, 
Alexander M, Mulvihill SJ, Golubovskaya VM, and Rosenblatt J. (2015). Defective 
apical extrusion signaling contributes to aggressive tumor hallmarks. eLife Jan 
26;4:e04069.
Chapter 4 is a published article.  Here, I contributed with data on Rac inhibitor, 
made S1P2 morphant fish and filmed them. Revised manuscript, acquisition of 
data, analysis and interpretation of data, drafting and revising the article.
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Defective apical extrusion signaling 
contributes to aggressive tumor hallmarks
Yapeng Gu1*, Jill Shea2, Gloria Slattum1, Matthew A Firpo2, Margaret Alexander1, 
Sean J Mulvihill2, Vita M Golubovskaya3, Jody Rosenblatt1*
1Huntsman Cancer Institute, University of Utah, Salt Lake City, United States; 
2Department of Surgery, University of Utah, Salt Lake City, United States; 
3Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo,  
United States
Abstract When epithelia become too crowded, some cells are extruded that later die. To extrude, 
a cell produces the lipid, Sphingosine 1-Phosphate (S1P), which activates S1P2 receptors in neighboring 
cells that seamlessly squeeze the cell out of the epithelium. Here, we find that extrusion defects 
can contribute to carcinogenesis and tumor progression. Tumors or epithelia lacking S1P2 cannot 
extrude cells apically and instead form apoptotic-resistant masses, possess poor barrier function, 
and shift extrusion basally beneath the epithelium, providing a potential mechanism for cell 
invasion. Exogenous S1P2 expression is sufficient to rescue apical extrusion, cell death, and 
reduce orthotopic pancreatic tumors and their metastases. Focal Adhesion Kinase (FAK) inhibitor 
can bypass extrusion defects and could, therefore, target pancreatic, lung, and colon tumors 
that lack S1P2 without affecting wild-type tissue.
DOI: 10.7554/eLife.04069.001
Introduction
Epithelial cells must act collectively to provide a protective barrier for the organs they encase even 
though they continuously turn over through cell death and division. The link between cell division and 
death is critical: if the relative death rate is too high, barrier function diseases may result whereas 
if division outpaces cell death, epithelia could become neoplastic. We previously identified a process 
critical for promoting cell death when cells within epithelia become overcrowded termed epithelial 
extrusion (Rosenblatt et al., 2001; Eisenhoffer et al., 2012). The stretch-activated channel Piezo-1 
senses cell crowding and enables some cells to produce the bioactive sphingolipid, Sphingosine 
1-phosphate (S1P), which binds G-protein coupled receptors (S1P2) in neighboring cells to activate 
Rho-mediated assembly and contraction of an intercellular actomyosin ring (Gu et al., 2011). This 
contraction squeezes live cells apically out of the epithelial sheet while simultaneously closing the gap 
that might have resulted from the cell's exit, thus preserving epithelial barrier function. Because live 
extruded cells become stripped from the underlying matrix and its associated survival signaling, they 
later die by anoikis (Frisch and Francis, 1994).
Advanced tumors typically have increased survival signaling that overrides anoikis, suggesting that 
cells could survive following extrusion. In this case, the direction a cell extrudes can impact its later 
fate. Typically, epithelia extrude cells apically into the lumen of the tissue (Slattum et al., 2009), which 
would act to essentially eliminate tumor cells with upregulated survival signaling. However, some cells 
are extruded basally into the tissue encased by the epithelium (Slattum et al., 2009). If basally 
extruded cells survive following extrusion, they might be able to invade into the underlying tissue 
(Slattum and Rosenblatt, 2014). Interestingly, we have found that oncogenic mutations in either 
adenomatous polyposis coli or K-Ras misregulate apical extrusion and drive extrusion basally (Marshall 
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Here, we examined the long-term effects of disrupting the S1P-S1P2 epithelia extrusion-signaling 
pathway. We found that inhibition of S1P2 leads to large epithelial masses in both zebrafish epidermis 
and cultured epithelia and increased rates of basal extrusion. Moreover, disrupting extrusion by a variety 
of methods leads to chemotherapy resistance. Inhibition of Focal Adhesion Kinase (FAK), a key survival 
signal generated from cell-matrix adhesion, selectively promotes apoptosis in cells where extrusion is 
defective and eliminates epidermal cell masses formed in zebrafish S1P2 mutants without affecting epi-
thelial morphology and function. Pancreatic Ductal Adenocarcinomas (PDACs) have little to no S1P2, 
which could explain why these tumors are typically more invasive and chemo-resistant. HPAF II human 
pancreatic cancer cells cannot extrude apically and instead extrude basally, survive, and proliferate fol-
lowing extrusion. Ectopically expressing S1P2 in HPAF II cells rescues apical extrusion and apoptosis and 
reduces orthotopic mouse tumors and their metastases. Together, our results suggest that defective 
extrusion may be a new mechanism for how PDACs and other carcinomas lacking S1P2 initiate and 
invade. Furthermore, FAK inhibitors, which are currently in clinical trials for other tumors, may provide an 
effective therapeutic opportunity to treat pancreatic cancer without destroying nearby normal tissue.
Results
Disruption of extrusion signaling reduces epithelial apoptosis rates
To test if the S1P-S1P2-Rho signaling pathway that controls extrusion (Gu et al., 2011) was critical for 
preventing neoplastic growth over time, we knocked down S1P2 in Human Bronchial Epithelial (HBE) 
cells (Figure 1A) and grew them for up to 3 weeks after they formed an intact monolayer. S1P2-
depleted HBE epithelia, which are extrusion-deficient (Gu et al., 2011), accumulated into masses over 
three layers thick whereas control-knockdown monolayers retained a single layer (Figure 1B). Because 
cell extrusion typically promotes epithelial cell death (Eisenhoffer et al., 2012; Marinari et al., 
2012) and because S1P2 depletion did not affect the proliferation rate in a yellow tetrazolium MTT 
(3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay (Figure 1C), masses were likely to 
eLife digest Epithelial cells cover the surface of our bodies, line our lungs, stomach and 
intestines and serve as a protective layer around other organs. If too many epithelial cells die and 
are not replaced, this protective layer may erode and lead to organ damage. However, if too many 
new cells grow, tumors can form.
One process that helps to maintain the right number of epithelial cells is called extrusion. 
When too many epithelial cells are present, the resulting overcrowding triggers this process to 
squeeze excess cells out of the layer and away from the organ. Usually, these cells quickly die. 
However, if the pathway that regulates this process—which involves a receptor protein called 
S1P2—is disturbed, the cells may instead be pushed into the space between the epithelial layer and 
the organ. When this happens, the cells are more likely to survive and may then form a tumor that 
invades the organ.
Gu et al. interfered with extrusion by reducing the levels of the S1P2 receptor in layers of human 
epithelial cells grown in the laboratory. Fewer epithelial cells were squeezed out of these cell layers, 
making the layers up to three times as thick in places. Moreover, mutant zebrafish lacking the S1P2 
receptor also accumulated epithelial masses throughout their bodies.
Gu et al. found that disrupting the extrusion process made the cells resistant to chemotherapy, 
and that certain hard-to-treat human pancreatic, lung, and colon cancers had lower levels of the 
S1P2 receptors. Boosting the activity of S1P2 receptors helped to restore normal extrusion and 
reduced the size of pancreatic tumors in mice.
Gu et al. then focused on an enzyme called Focal Adhesion Kinase that helps cells to survive. Treating 
zebrafish with a drug to block the activity of this enzyme left normal fish unharmed. However, in 
mutant fish with malfunctioning extrusion pathways, the drug rescued the number of cells that died, 
reduced the size and number of masses, and cured their leaky skin barrier. If further studies confirm 
the results, the drug may offer a new, less toxic, treatment for certain cancers that do not respond 
to currently available treatments.
DOI: 10.7554/eLife.04069.002
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arise due to reduced apoptosis. Additionally, zebrafish larvae carrying a loss-of-function mutation in 
S1P2 (Miles apart [Mil]) cannot extrude apoptotic epidermal cells (Gu et al., 2011), and similarly accu-
mulated numerous epidermal cell aggregates throughout the body (18 ± 3.5 aggregates/fish, n = 22) 
by only 5 days post fertilization (dpf) (Figure 1D,E). By contrast, masses were undetectable in hetero-
zygote Mil or WT siblings of the same age (Figure 1D,E).
We next wondered if extrusion-deficient cells were also more resistant to cell death in response 
to apoptotic stimuli. While extrusion promotes apoptosis during normal homeostasis by extruding 
live cells that later die from loss of contact to matrix-derived survival signaling (Eisenhoffer et al., 
2012), treating epithelia with apoptotic stimuli causes cells to simultaneously die and extrude 
(Rosenblatt et al., 2001; Andrade and Rosenblatt, 2011). Because extrusion normally drives cell 
death, could it also help promote apoptosis in response to apoptotic stimuli by eliminating compet-
ing survival signaling associated with the underlying matrix? We find that disrupting extrusion signal-
ing also disrupted apoptosis in response to a variety of apoptotic stimuli. HBE monolayers lacking 
S1P2 (Figure 2A) or treated with a selective S1P2 receptor antagonist, JTE-013 (Figure 2B) had 
greatly reduced rates of apoptosis in response to a strong apoptotic stimulus, UV-C, compared to 
controls. Madin–Darby Canine Kidney (MDCK) monolayers treated with S1P2 antagonist were simi-
larly resistant to several common chemotherapy drugs that cause apoptosis (Figure 2B,C).
Figure 1. Loss of S1P2 and extrusion leads to accumulation of epithelial cell masses. (A) S1P2 immunoblot of HBE cells expressing control (left)  
or S1P2-specific shRNA (right) with α-tubulin as loading control. (B) Representative images of HBE cells (DNA only) expressing control (left) or S1P2-specific 
shRNA (right) grown for 3 weeks. Scale bar, 10 µm. (C) Proliferation assay indicates that S1P2-knockdown cells proliferate at the same rate as wild type 
controls cells. (D) Representative DIC micrographs of 5-dpf WT (top) and Mil (S1P2 mutant) (bottom) zebrafish larvae, where cartoon shows region where 
fish was imaged. Scale bars, 100 µm where red box indicates region imaged. (E) Quantification of epidermal clumps of 22 zebrafish larvae.
DOI: 10.7554/eLife.04069.003
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The reduced cell death rates in epithelia lacking S1P2 were due to disruption of extrusion rather 
than altered S1P signaling, since other inhibitors of extrusion, Rho kinase inhibitor (Y-27632), myosin II 
inhibitor (Blebbistatin), or Rac inhibitor (EHT1864) all decreased cell death rates to the extent that 
they inhibit extrusion (Figure 3A). In each case, the ratio of cell death to extrusion inhibition is ∼1:1 
(Figure 3C). Inhibition of apoptosis was not due to increasing levels of S1P, which can act as a pro-
survival signal, as S1P levels in apoptotic cells varied independently of extrusion inhibition (Figure 3B). 
Since freshly plated single MDCK cells are resistant to apoptotic stimuli, we tested if these same com-
pounds reduced apoptosis in similarly aged single MDCKs by treating with EGTA to disrupt cadherin-
dependent cell–cell contacts. Inhibitors that blocked apoptosis by blocking extrusion in an intact 
monolayer do not impact the apoptosis rates of single cells that are incapable of extrusion (Figure 3D). 
Similarly, UV-induced apoptosis was unaltered in single HBE cells lacking S1P2 when HBE monolayers 
where treated with EGTA (Figure 3D). Additionally, inhibiting S1P2 with JTE-013 in a cell line that 
cannot extrude but expresses this receptor (Clair et al., 2003; Pham et al., 2013), NIH 3T3 fibroblasts, 
does not affect the cell death rate in response to UV-C (Figure 3E). These data together suggest 
that increased cell survival is linked with the inability to extrude rather than to any intrinsic block of the 
apoptosis pathway.
Pancreatic cancer cells lack the S1P2 receptor and extrude basally 
rather than apically
Since disruption of S1P2 in epithelia results in reduced apoptosis and cellular masses both in vitro and 
in vivo, we wondered if this receptor might be deficient in carcinomas. Our analysis of published tumor 
microarray data found S1P2 mRNA to be significantly reduced in PDAC (Buchholz et al., 2005; Segara 
et al., 2005; Badea et al., 2008), and some lung and colon tumors (Bhattacharjee et al., 2001), 
compared to their corresponding normal tissues. To investigate if cancer cells lacking S1P2 also have 
extrusion and apoptosis defects, we analyzed a pancreatic adenocarcinoma cell line, HPAF II, that 
has reduced S1P2 levels (Figure 4A) and forms epithelial monolayers necessary for assaying extru-
sion. We used MDCK and HBE cells as controls, which are well characterized in several extrusion 
studies (Rosenblatt et al., 2001; Slattum et al., 2009; Gu et al., 2011), as the only immortalized 
normal pancreatic cells, HPDEs, cannot form a confluent monolayer (data not shown).
Our experiments show that the reduced S1P2 levels in HPAF II cells disrupted apical extrusion, 
leading to reduced apoptosis rates and enhanced basal extrusion. Similar to HBE monolayers lacking 
S1P2, HPAF II cells formed masses within a week of culture and displayed extrusion defects and 
reduced rates of UV-C-induce apoptosis (Figure 4A–D). While ∼50% of cells did not extrude, most of 
the remaining cells extruded in the opposite direction—basally, underneath the layer (Figure 4D,E) at 
Figure 2. Disruption of S1P2-extrusion signaling reduces apoptotic response. (A) Quantification of UV-induced apoptotic cells in HBE monolayers 
expressing control or S1P2-specific shRNA. (B) Quantification of UV-induced apoptosis of HBE monolayers in the presence or absence of the S1P2 
antagonist JTE-013. (C) Quantification of indicated chemotherapy-induced apoptotic MDCK cells in the presence or absence of JTE-013, where all error 
bars are STD (**p < 0.01, and ***p < 0.001).
DOI: 10.7554/eLife.04069.004
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rates similar to when MDCK monolayers are treated with S1P2 antagonist (Slattum et al., 2014). Basal 
extrusion of cells with upregulated survival signaling could potentially enable their invasion beneath 
the epithelium (Slattum and Rosenblatt, 2014). To investigate if basally extruded cells can survive 
following extrusion (Slattum and Rosenblatt, 2014), we analyzed extrusion from three-dimensional 
cysts, where the fate of basally extruded cells can be followed outside the cyst, rather than beneath 
a monolayer. MDCKs were used as controls, which, like HPAF II cells, form cysts with hollow apical 
lumens of 34 µm ± 5 µm in diameter when grown in Matrigel (Figure 5B). Approximately 30% of HPAF 
II cysts extrude cells basally that survive, compared to only ∼3% of MDCK cysts (Figure 5C,D). Live 
imaging confirmed that 28.6% of basally extruded cells remained alive throughout a 12-hr video, whereas 
those from MDCK cysts died during this time (Video 1, n = 5 videos of each). Importantly, S1P2-GFP 
expression is sufficient to rescue apical extrusion (Figure 5C), decrease the frequency of live cells that 
basally extrude (Figure 5D), and increase the percentage of cysts with dead cells in their lumens 
(Figure 5E). These data suggest that the S1P-S1P2 signaling required for extrusion is critical not only for 
promoting cell death but also for preventing basal extrusion, which could enable cells to invade.
Figure 3. Decreased apoptosis is due to blocked extrusion rather than S1P signaling. (A) Rates of MDCK cell death (left Y-axis, blue) correspond with cell 
extrusion rates (right Y-axis, yellow) in response to UV-C when treated with extrusion inhibitors. (B) Representative images of apoptotic cells with and without 
compounds that block extrusion. When extrusion occurs, the dying cell DNA lies above (out of plane from) the neighboring cells with a contracted 
actin ring but when it fails, it lies in the same plane as surrounding cells with an uncontracted actin ring. Only the S1P2 antagonist JTE013 causes 
significant S1P accumulation in the dying cell (second column), whereas blocking extrusion with the other compounds does not impact S1P levels, 
where p values of each drug treatment compared to control are listed on each S1P panel as asterisks (n = 4). Bar = 10 µm. (C) Ratio of reduction of 
extrusion to reduction of apoptosis shows nearly a 1:1 correlation throughout, where p-values compared to S1P2 are not significant. (D) Compounds 
used to block extrusion do not affect apoptosis rates in single MDCK cells treated with EGTA in response to UV. (E) Quantification of UV-induced 
apoptotic NIH 3T3 cells in the presence of vehicle or JTE-013; All results are expressed as mean values ± STD of three separate experiments  
(*p < 0.01, **p < 0.005, ***p < 0.005, and ****p < 0.0001), and NS in graphs B, D, and E indicate that p values of a unpaired T-test are not significant.
DOI: 10.7554/eLife.04069.005
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Figure 4. Pancreatic cancer cell line HPAF II accumulates into masses and extrudes basally. (A) S1P2 immunoblot of HBE (left), HPAF II (middle), and 
MDCK (left) cells with α-tubulin as loading control. (B) Cell death rates in response to UV-C. (C) Quantification of cell extrusion events from three 
independent experiments; n = 300 apoptotic cells per cell line, error bars are STD where *<0.01 and ***<0.0001. (D) Representative confocal projection 
and XZ cross-section (from region in dashed line above) of HPAF II cells that grew into masses rather than monolayers. (E) Representative confocal 
projections of HPAF II (upper panel) and HBE (lower panel) cells undergoing apical (left) or basal (middle) extrusion, with XZ sections below. Basal 
extrusion was scored when an actin ring contracted above the dying cell (marked by DNA and caspase-3 staining) and the DNA of the dying cell 
lies in the same plane as the neighboring cells. Scale bars, 10 µm.
DOI: 10.7554/eLife.04069.006
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Inhibiting FAK rescues cell death rates in epithelia defective in 
extrusion
Because extrusion promotes cell death in response to apoptotic stimuli (Rosenblatt et al., 2001; 
Andrade and Rosenblatt, 2011) and during normal homeostasis (Eisenhoffer et al., 2012; 
Marinari et al., 2012), we hypothesized that it does so by eliminating the competing survival 
signaling associated with cell-matrix attachment. If so, increased cell survival when extrusion is blocked 
would derive from prolonged cell attachment to the underlying matrix. Since Focal Adhesion 
Kinase (FAK) is critical for matrix-dependent survival (Frisch et al., 1996), we investigated if FAK 
were increased in cells targeted for death when extrusion was blocked. Surprisingly, we found that 
control MDCK cells in early stages of extrusion have far higher levels of active FAK, by immu-
nostaining with a phospho-FAK antibody, than surrounding live cells but that these levels decrease 
during later stages of extrusion (Figure 6A). This increase in pro-survival phospho-FAK in cells 
targeted to die mimics the increased levels of S1P, another pro-survival signal, in cells triggered to 
extrude and die that also decrease once cells extrude (Figure 3C and [Gu et al., 2011]). However, 
late-staged apoptotic cells (detected by piknotic DNA) still have high levels of active FAK when 
extrusion is blocked with S1P2 antagonist (Figure 6A). This paradoxical survival signaling increase 
in cells targeted to die may reflect cell-intrinsic compensatory signals to apoptotic signaling that 
eventually decrease as cells commit to apoptosis. The fact that these survival signals stay high 
when cell extrusion is blocked suggests that this increased survival signaling derives from inability 
to detach from matrix.
Figure 5. Exogenous expression of S1P2 rescues apical extrusion and cell death. (A) GFP immunoblot of HPAF II cells expressing S1P2 GFP.  
(B) Representative confocal projections of MDCK, HPAF II, and HPAF II-S1P2 cysts, where scale bar = 10 µm. (C) Percentages of MDCK, HPAF II GFP, and 
HPAF II S1P2 cysts with basal extrusion; n = 300 cysts per cell line. (D) Quantification of MDCK, HPAF II GFP, and HPAF II S1P2 cysts extruding live cells 
basally; n = 300 cysts per cell line. (E) Frequency of HPAF II GFP and HPAF II S1P2 cysts with dying cells inside the lumen; n = 300 cysts per cell line. All 
results are expressed as mean values ± STD of three separate experiments (**p < 0.01, and ***p < 0.001).
DOI: 10.7554/eLife.04069.007
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Because FAK activity remains high in cells 
where extrusion is blocked, we wondered if 
chemically blocking FAK activation would rescue 
the apoptosis rates of monolayers lacking functional 
S1P2 signaling. The specific FAK inhibitor PF 
573228 had no effect on untreated or UV-treated 
wild type monolayers (Figure 6B and [Slack-
Davis et al., 2007]), likely because cells not tar-
geted to extrude have quite low levels of active 
FAK (Figure 6A). However, this same FAK inhib-
itor rescued the cell death rates of monolayers 
where extrusion is blocked with S1P2 antagonist 
JTE013 or Rac inhibitor to those seen in wild 
type monolayers (Figure 6B). FAK inhibitor dra-
matically decreased phospho-FAK staining in 
cells where JTE013 blocks extrusion (Figure 6A). 
Over-expression of a dominant negative FAK 
isoform (FRNK) (Park et al., 2004) acted simi-
larly to FAK inhibitor (Figure 6C). Importantly, 
FAK inhibitor alone induced apoptosis of HPAF II 
cells in monolayers (Figure 6D) and even those 
basally extruding from HPAF II cysts (Figure 6E,F). 
Additionally, treatment with FAK inhibitor to cysts 
that had already accumulated live basally extruded cells was sufficient to nearly double apoptosis 
rates of basally extruded cells (from 15 ± 2% to 28 ± 3%) when added for only 2 hr.
FAK inhibitor eliminates S1P2 mutant zebrafish embryo epidermal 
masses and improves epidermal barrier function
Because inhibition of FAK appears to promote cell death of only extrusion-defective epithelial cells 
without affecting normal epithelia, we wondered if FAK inhibition could eliminate the epidermal 
masses of Mil zebrafish embryos as they formed without adversely impacting the animal. While FAK 
inhibitor had no visible effect on wild-type zebrafish at 5 dpf, it greatly decreased the number and size 
of epidermal cell masses in S1P2-mutant embryos of the same age (Figure 7A–C). While FAK inhibitor 
treatment sloughed off many of the epidermal cells, which could be found at the bottom of the dish, 
it also increased the apoptosis rate within the masses (Figure 7D). To test if FAK inhibitor could elimi-
nate epidermal masses after they form, we needed to inducibly knockdown S1P2 later in development, 
since Mil zebrafish mutants die due to heart defects around the time cell masses form (∼5 dpf; 
[Kupperman et al., 2000]). To do so, we used we photo-activated S1P2 morpholino at 24 hpf 
(see [Eisenhoffer et al., 2012] for characterization of this method) to knockdown S1P2 after heart 
development occurred. S1P2 morphants had 0.18-fold lower S1P2 protein levels (Figure 7E) and 
phenocopied the epidermal masses seen in Mil mutants (Figure 7F). Addition of FAK inhibitor to 
an S1P2 morphant at 5 dpf with epidermal masses caused the masses to slough off within 19 hr 
(Figure 7F, where n = 6 videos total). Remarkably, we found that while Mil embryos had poor 
epidermal barrier function, as assayed by Texas Red-DextranMW70 permeability, epidermal permeability 
was significantly reduced with FAK inhibitor (Figure 7A). These results suggest that FAK inhibitor alone 
may selectively target masses resulting from cells defective in extrusion and improve overall epithelial 
integrity without affecting the normal surrounding tissue.
Expression of S1P2 is sufficient to reduce orthotopic pancreatic tumors 
and their metastases
We have shown that disrupting S1P/S1P2 signaling inhibits epithelial cell death, causes masses, and 
promotes a potential mechanism for invasion—basal extrusion, which together could promote tumor 
formation and progression. Yet, it was not clear if this signaling pathway plays a role in malignancy. To 
test the role of S1P2 in tumorigenesis, we orthotopically transplanted HPAF II tumor cells expressing 
either GFP or S1P2-GFP into nude mice and found that S1P2 expression was sufficient to markedly 
reduce both tumor size and metastatic frequency (Figure 8A,B).
Video 1. An HPAF II cyst growing without apoptotic 
stimuli extrudes live cells basally. Note that some cells 
extrude and die while others survive and/or migrate away.
DOI: 10.7554/eLife.04069.008
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Figure 6. Inhibition of FAK activity specifically increases cell death in epithelial cells lacking S1P2. (A) Immunostaining of active phospho-FAK in 
early and late control extrusions and in a JTE-013 (S1P2 antagonist)-inhibited extrusion with late apoptotic cell or one with the FAK inhibitor 
PF573228, with averaged arbitrary fluorescence units and their p-values compared to early extruding cells in graph on right (n = 10 measurements 
each over three separate experiments). (B) Quantification of UV-induced MDCK apoptosis in the presence of control, JTE-013, or EHT1864 with or 
without treatment of the FAK inhibitor PF573228, where n = 3000. (C) Quantification of UV-induced apoptosis of MDCK cells and those expressing 
FRNK, where n = 3000. (D) Quantification of PF573228-induced apoptosis of HPAF II cells, where n = 3000. (E) Representative confocal projections 
of HPAF II cysts treated with control or PF573228. Scale bars = 10 µm. (F) Frequencies of HPAF II cysts with dying cells, live extruding cells, or neither, 
where n = 300. All quantification results are expressed as mean values ± STD of three separate experiments (*p < 0.05, **p < 0.01, ***p < 0.001, 
and ****p < 0.0001).
DOI: 10.7554/eLife.04069.009
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Human pancreatic ductal carcinomas lack S1P2 receptor
Further, we found that human pancreatic carcinomas have strikingly down-regulated S1P2 protein 
levels. Because tumors typically have different stromal to epithelial ratios compared to uninvolved 
pancreatic tissue that can confound microarray data, we immunostained fixed tissue slices for both 
S1P2 and cytokeratin to highlight epithelial cells so that we could compare S1P2 protein levels in the 
epithelia alone (Figure 9A). We found that S1P2 was significantly lower in pancreatic cancer (PDAC) 
cells compared to epithelial acini from uninvolved neck margins, from which PDACs may arise, or to 
pancreatic intraepithelial neoplasia (PanIN) precursor lesions (Figure 9A–C). Importantly, lower S1P2 
expression correlates with later tumor stages in both averaged (Figure 9B) and five patient-matched 
samples (Figure 9C). Loss of S1P2 expression in pancreatic cancers suggests that defective extrusion 
may contribute to human PDAC development.
Figure 7. FAK inhibitors eliminate epidermal cell masses in S1P2 zebrafish mutants and improve epidermal barrier function without affecting wild type 
zebrafish. (A) Representative confocal projections of 5-dpf WT (left) and Mil (S1P2 mutant) (right) zebrafish larvae treated with DMSO or FAK inhibitor 
PF573228, where high Texas-Red Dextran indicates poor permeability in Mil but is greatly reduced when barrier function is improved with FAK inhibitor 
treatment. Scale bar = 10 µm and red box indicates region of fish imaged. (B) 5 dpf Mil and wild type zebrafish treated with and without FAK inhibitor. 
Note that while FAK inhibitor-treated Mil have other developmental defects (heart and circulation), there are no obvious clumps as seen in the untreated 
fish. Scale bar = 100 µm and red box indicates region of fish imaged. Note FAK inhibitor does not affect WT zebrafish. (C) Quantification of epidermal 
masses in 5 dpf Mil zebrafish larvae with and without PF573228. (D) Quantification of apoptotic cells within epidermal masses with and without PF573228. 
For both, error bars are SD and p values are ***<0.0001. (E) Immunoblot showing knockdown of S1P2 by photo-activatable morpholinos. (F) Stills from a 
video where PF573228 was added to S1P2 morphant at 5 dpf, where red arrows show the edge of the epidermis over time, scale bar = 50 µm and red 
box indicates region of fish imaged. Time is hours:minutes following FAK inhibitor addition. Note: epidermal cells that are sloughed off become 
embedded in the agarose where fish is mounted.
DOI: 10.7554/eLife.04069.010
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Discussion
Our work presents a new paradigm for how an aggressive class of carcinomas may form and progress: 
failed extrusion (Figure 10). Normal epithelial cells produce S1P to trigger their extrusion and death 
once they become too crowded, simultaneously maintaining correct cell density and barrier function. 
Epithelia with defective S1P/S1P2 signaling cannot extrude apically. Extrusion-defective epithelia 
retain cells, which can result in resistance to homeostatic and chemotherapy-induced cell death and 
neoplastic masses. Further, a small number of cells also die without getting extruded, which can dis-
rupt barrier function. Aside from allowing access of inappropriate signals, poor epithelia barrier func-
tion could cause chronic inflammation—an important factor for tumor progression (Coussens and 
Werb, 2002). Additionally, defective apical extrusion signaling shifts extrusion basally, which could 
allow transformed cells to invade the underlying tissue (Slattum and Rosenblatt, 2014).
Basal extrusion may be a common hallmark of invasive tumor types. We have recently discovered 
that oncogenic KRasV12 expression degrades S1P through autophagy and causes cell masses and basal 
extrusion, similar to the extrusion defects observed when S1P2 is absent (Slattum et al., 2014). KRasV12 
is an important driver for the same cancers that lack S1P2—pancreatic, lung, and colon carcinomas—
and its expression alone reduces S1P2 (Slattum et al., 2014), which may explain why PanIN precursors 
have reduced S1P2 expression. Further, we have found that another oncogenic mutation, truncation of 
the adenomatous polyposis coli gene, also results in increased basal extrusion. While it is not clear 
what mechanisms drive tumor cell invasion, our work showing that exogenous expression of S1P2 can 
dramatically reduce basal extrusion rates and orthotopic tumor metastasis rates in tumor cells that lack 
this receptor suggests that S1P2-mediated extrusion may play an important role in metastatic cell 
invasion.
Because cancer cells lacking S1P2 have increased survival signaling due to an inability to detach 
from the matrix and its associated survival signaling through increased active FAK, we found that 
FAK inhibitor on its own could rescue cell death rates to those seen in wild type cells (Figure 7D). 
Surprisingly, FAK inhibitor could also reverse other extrusion defects, such as poor barrier function and 
survival of basally extruded cells, factors that together could contribute to tumor progression. The fact 
that adding FAK inhibitor can rescue these defects when added after they form further supports the 
notion that anoikis results from extrusion and also suggests that FAK inhibitors may be particularly 
good at treating pancreatic and other carcinomas defective in extrusion. Moreover, we expect a spe-
cific FAK inhibitor to not cause the common toxicities associated with standard chemotherapies, as it 
does not affect normal epithelial tissue. Another FAK inhibitor, PF-00562271, reduces tumor growth, 
metastases, and ameliorates tumor microenvironment when used in an orthotopic mouse model for 
pancreatic cancer (Stokes et al., 2011), suggesting this drug could be promising for pancreatic cancer 
patients. However, it is important to note that PF-00562271 also inhibits a FAK-related kinase Pyk-2, 
which promotes non-specific cell death (Schultze and Fiedler, 2011). The phase I clinical trial for 
PF-00562271 showed that while this drug was tolerated fairly well, it did cause nausea, vomiting, 
and diarrhea (Infante et al., 2012), symptoms indicative of poor gut barrier function, likely due to 
Figure 8. Exogenous S1P2 expression reduces orthotopic pancreatic tumors and rates of metastasis in mice. 
(A) Representative images of HPAF II GFP and HPAF II S1P2 orthotopic xenograft tumors in nude mice. (B) Summary 
of tumor weights and metastatic frequency.
DOI: 10.7554/eLife.04069.011
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excessive non-specific apoptosis. Our results suggest that a newer more specific FAK inhibitor, such as 
VS-4718 (Shapiro et al., 2014), may provide a more targeted therapy for patients with pancreatic and 
lung carcinomas that have aberrant extrusion signaling without the common toxicities associated with 
older chemotherapies.
Based on our previous findings that extrusion drives normal epithelial cell turnover, we have found 
that disruption of extrusion may contribute to a class of cancers with poor prognosis. We find that 
cancer cells that lack the extrusion-signaling axis not only have reduced cell death rates but also have 
poor barrier function and a propensity to extrude cells basally, properties that could lead to higher 
invasion and metastatic rates. Therefore, aberrant extrusion signaling in pancreatic and lung carcino-
mas could not only contribute to tumor initiation but also progression. Importantly, specific inhibition 
of FAK, which does not disrupt normal epithelial tissue, is sufficient to reverse all of the effects of dis-
rupted extrusion and could provide a better, less toxic therapy for this aggressive class of tumors.
Materials and methods
Cell culture
MDCK II cells were cultured in Dulbecco's minimum essential medium (DMEM) high glucose with 5% 
FBS (all from HyClone, Logan, UT) and 100 μg/ml penicillin/streptomycin (Invitrogen, Grand Island, NY) 
at 5% CO2, 37°C. HBE cells were cultured in MEM supplemented with 10% FBS and l-glutamine in a 
flask coated with human fibronectin type I (BD, Franklin Lakes, New Jersey), bovine collagen I 
(Advanced BioMatrix, San Diego, CA), and BSA (Invitrogen). HPAF II cells were cultured in MEM 
(HyClone) supplemented with 10% FBS.
Figure 9. Human pancreatic tumors have reduced S1P2 expression. (A) H&E (top panel) and confocal fluorescence images (middle and bottom panel) 
of normal acinar cells from uninvolved neck margin, PanIN, and invasive cancer cells. Scale bars, 100 and 10 µm, respectively. (B) Quantification of 
S1P2 fluorescence intensity in acinar cells, PanIN, and invasive cancer cells from five individual patients. p values were calculated with a paired t test. 
(C) Changes of S1P2 fluorescence intensity from normal acinar cells to invasive cancer cells in each individual patient.
DOI: 10.7554/eLife.04069.012
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Culturing HPAF II and MDCK cells in Matrigel 
generated HPAF II and MDCK cysts, respectively. 
Briefly, a single cell suspension of HPAF II cells 
was resuspended in Growth Factor Reduced 
Matrigel (BD Biosciences) final concentration 4% 
and placed in eight well coverglass chambers 
(Nalge Nunc, Rochester, NY) coated with a thin 
polymerized layer of Matrigel. For live imaging, 
cells were placed on 24 well glass-bottom culture 
dishes (MatTeK Corporation, Ashland, MA). After 
20 min incubation at 37°C, cell-growth medium 
was added on top. Cysts were allowed to grow 
for the indicated duration and analyzed by time-
lapse imaging or fixed with 4% paraformaldehyde 
for immunostaining.
Generation of stable Doxycyclin-
inducible MDCK II cells over-
expressing dominant negative FAK
We first transfected MDCK II cells with neomycin-
resistant pTet-ON regulator plasmid, encoding 
rtTA protein (reverse tTA, tetracycline-controlled 
transactivator). The stable transfected MDCK II 
cells were selected by cultivation in media con-
taining 500 μg/ml G418. We then transfected 
Tet-ON MDCK II cells with FAK-CD-TRE-2-hyg plas-
mids (Golubovskaya et al., 2009) and selected for 
stably transfected cells with 0.1 mg/ml hygromycin. 
Expression of FAK-CD was induced with 2 µg/ml 
doxycycline for 4 days.
UV and drug treatment
MDCK II, HBE, or HPAF II cells grown to confluence 
on glass coverslips were exposed to 1200 μJ/cm2 
UV254 using a Spectrolinker (Spectroline, Westbury, 
NY) to induce apoptotic extrusion and incubated 
for 2 hr before fixation. Cells were treated with 
10 μM JTE-013 (Tocris Bioscience, United Kingdom), 
10 μM Y-27632, 10 μM Blebbistatin, 10 μM EHT 
1864 (all from Sigma–Aldrich, Saint Louis, MO), 
10 μM PF 573228 (Tocris Bioscience) or 1% DMSO 
as a control for 10 min before UV treatment. To 
induce apoptosis with chemotherapy drugs, cells 
were treated with 20 μg/ml Cisplatin, 1 μM Gemcitabine, or 20 μg/ml 5-Fluorouracil (all from Sigma–
Aldrich) for 24 hr.
Cell staining
Cells were fixed with 4% formaldehyde in PBS at 37°C for 20 min, permeabilized for 10 min 
with 0.5% Triton in PBS, blocked with AbDil (PBS with 0.1% Triton X-100 and 2% BSA) for 10 min, 
and incubated with primary antibody for 1 hr. Antibody concentrations used for immunostaining 
were: 1:200 rabbit anti-active caspase-3 (BD), 1:100 rabbit anti-phospho FAK (Tyr 397) (Cell 
Signaling, Danvers, Massachusetts), and 50 μg/ml anti-S1P mAb (LPath Inc., San Diego, CA). 
Alexa Fluor 488 goat anti–rabbit IgG and Alexa Fluor 488 goat anti–mouse IgG were used as 
secondary antibodies to detect active caspase-3 and S1P, respectively. Actin was detected 
with Alexa Fluor 568–phalloidin (Invitrogen). DNA was detected with 1 μg/ml Hoechst 33,342 
(Sigma–Aldrich).
Figure 10. Model for how extrusion can promote cell 
death and suppress tumor formation. Apical extrusion 
promotes death of grey-blue cell (top panel). Here, 
pro-survival signals phospho-FAK and S1P (which also 
promotes extrusion) increase in an early extruding cell 
but decrease once a cell is extruded and targeted to 
die (right, cell with piknotic nucleus). However, when 
apical extrusion is blocked due to lack of S1P2 receptor 
(bottom panel), epithelial cells do not die and can 
accumulate (left cell and those accumulating above) 
from increased matrix-derived survival signaling 
(arrows from matrix neighboring cells signaling to 
P-FAK). Additionally, cells can still basally extrude, 
which could potentially enable their invasion beneath 
the layer (right cell). Basally extruded cells may also 
have high P-FAK, since they are sensitive to FAK 
inhibitor when extruded into matrix in vitro, yet this 
point will be critical to test in vivo in disseminating 
tumors. Other cells may still die but not extrude 
(grey-blue cell with piknotic nucleus), leading to poor 
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Human pancreatic sections
Pancreatic tissue sections (3 µm) were generated from formalin-fixed, paraffin-embedded tissue col-
lected from PDAC patient resections at the University of Utah Hospital. The sections were deparaffinised 
and rehydrated by incubating in citrus clearing solvent (CCS; Richard Allen Scientific, Kalamazoo, MI), 
100%, 95%, 80%, 70% ethanol, and PBS. For immunofluorescence, antigens were retrieved by heating 
the slides in boiling 10 mM sodium citrate for 20 min, then rinsed three times with PBS, blocked with 
5% BSA/0.5% Tween-20 in PBS for 4 hr, and incubated overnight with anti-S1P2 (Imgenex, San 
Diego, CA) and anti-pan cytokeratin (Sigma–Aldrich) at 4°C, rinsed five times with PBS, incubated in 
Alexa-488 anti-mouse antibody, 1 µg ml−1 Hoechst, and Alexa-568 anti-rabbit antibody for 2 hr, rinsed 
three times in PBS, and mounted in Prolong Gold (Invitrogen). Fluorescence micrographs of stained 
slides were obtained using a Leica DM 6000B microscope and captured using a Micromax charge- 
coupled device camera (Roper Scientific, Sarasota, Florida). IPlab Software was used to control the 
camera and to process images. Pixel intensity interested area was measured with ImageJ. The 
University of Utah Institutional Review Board approved the use of human tissue in this study. Tissue 
sections were obtained from excess clinical pathology tissue from patients, deidentified, resected for 
pancreatic adenocarcinoma at the University of Utah Huntsman Cancer Institute with appropriate 
informed consent for use of samples for research purposes (IRB_00010924).
Zebrafish treatment and staining
We sorted Mil zebrafish embryos from their WT homozygous and heterozygous siblings at 2 days post-
fertilization (dpf) by the presence or absence of tail blisters. We then treated half of Mil mutants and 
half of the wild type siblings with FAK inhibitor (10 μM PF 573228) for 3 days and added Texas Red-
DextranMW70 30 min before fixation. Embryos were then fixed in PBS with 4% formaldehyde and 0.1% 
Triton X-100 overnight, blocked with 2 mg/ml BSA for 2 hr, and stained for anti-E Cadherin (Gentex, 
Zeeland: MI) for 4 hr followed by incubation with Alexa Fluor 488 anti–rabbit IgG Ab. DNA was 
visualized using 1 μg/ml DAPI.
Zebrafish morpholino
The antisense morpholino oligonucleotides and photo-morpholino oligonucleotides were acquired 
from Gene Tools, LLC (Philomath, OR). For the photo-morpholino experiments, the translation blocking 
antisense morpholino (4 ng/embryo of each) was mixed at a 1:1 molar ratio with a 25 bp sense photo-
morpholino and injected into 1–2-cell-stage wild-type AB zebrafish embryos. At 28–32 hpf, embryos 
were exposed to 350 nm light for 20 s to release the caging sense morpholino, then treated with 10 μM 
PF 573228 (FAK inhibitor), and filmed by timelapse video microscopy on a spinning disc confocal.
Image and video acquisition
Confocal Imaging was performed in a Nikon Eclipse TE300 inverted microscope converted for spin-
ning disc confocal microscopy (Andor Technologies, United Kingdom) using a 40× Nikon Apo LWD 
lenses. Images were acquired with an electron-multiplied cooled charge-coupled device camera 
(DV887 1004X1002; Andor Technologies) driven by Andor IQ2 imaging software. All images were 
processed further using Photoshop and Illustrator (Adobe, San Jose, CA), and QuickTime Pro (Apple, 
San Jose, CA) software.
Live imaging of HPAF II cysts was taken with an OLYMPUS 1X71 inverted microscope using 
a 20× lens. The images were taken every 5 min for 12 hr. Temperature was controlled by a Weather 
station connected to the microscope.
For live imaging, FAK inhibitor treated S1P2 morpholino fish were anesthetized with 0.02% Tricaine 
in E3, mounted in 1% low melt agarose and imaged on a spinning disc confocal at 20×, capturing 
a z-series every 2 min (Eisenhoffer and Rosenblatt, in press) for 3–6 hr.
Quantification of apoptosis and cell extrusion
To quantify the frequency of apoptosis within a monolayer, we counted the number of active caspase-3 
positive cells still in contact with the monolayer per 1000 cells. We excluded round cells with strong 
caspase-3 staining that were not associated with monolayers, which were likely extruded well before 
experimental treatments could have impacted them.
To quantify extrusion, extruding cells were manually scored based on the presence of an actin ring 
compared to where apoptotic cell localized with respect to its neighboring cells. Apoptotic cells above 
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the plane of the monolayer with strong actin staining around and below them were defined as apically 
extruded cells. Apoptotic cells remaining in the monolayer and underneath an apical actin ring were 
considered basally extruded cells. Active caspase-3-positive cells that were not surrounded by a dis-
tinguishable actin ring were defined as non-extruded apoptotic cells.
Immunoblot analysis
Whole-cell extracts were prepared by resuspending cells in NP40 Cell Lysis Buffer (Invitrogen) plus 
protease inhibitor cocktail and PMSF (Roche, Switzerland). Proteins were resolved by SDS-PAGE 
using NuPage gels (Invitrogen), and transferred to polyvinylidene difluoride membrane (Thermo, 
Waltham, MA). Membranes were blocked with 5% dry milk and probed with anti-tubulin 1:1000 
(Sigma–Aldrich) and anti-GFP 1:10,000 (Clontech, Mountain View, CA) or anti S1P2 1:500 (Santa Cruz, 
Santa Cruz, CA) and identified using horseradish peroxidase conjugated secondary antibodies and 
enhanced chemiluminescense.
Molecular cloning
pLL5.0 is a lentiviral expression plasmid containing a U6 promoter to drive expression of the shRNA 
sequence and a 5′-long terminal repeat to drive the expression of GFP. Designing and cloning of S1P2-
specific shRNA were performed as previously described (Gu et al., 2011). The full length of human 
S1P2 was PCR amplified and ligated into the EcoRI/BamHI sites of pLL5.0.
Lentiviral production and transduction
Retroviral production and infections were as described (Gu et al., 2011). Infected HPAF II or HBE cells 
were sorted for GFP by using a BD FACSAria Cell Sorter.
Surgical orthotopic pancreatic cancer xenograft mouse model
Animals were handled according to protocols approved by the University of Utah Institutional Animal 
Care and Use Committee. Mice were anesthetized under isoflurane gas; the abdominal skin and muscle 
were incised just off the midline and directly above the pancreas to allow visualization of the pancreatic 
lobes; the pancreas was gently retracted and positioned to allow for direct injection of a 100 µl bolus 
of 1 × 106 HPAF II cells expressing GFP or S1P2 GFP using a 1 cc syringe with a 30 gauge needle; the 
pancreas was placed back within the abdominal cavity; and both the muscle and skin layers were closed. 
8 weeks later, mice were sacrificed and xenograft tumors were resected and weighed. Metastatic tumors 
within abdominal wall, liver, and mesentery were also examined and resected.
Quantifications
P-FAK was quantified using Nikon Elements as the ‘ROI Sum Intensity’ on ROI statistics using the same 
ROI size for each projection micrograph measured, subtracting background average fluorescence. 
Lumen sizes were also measured using Nikon Elements using ‘Radius size’ using the largest diameter 
in the ‘Annotations and Measurements’ analysis package. The statistical analysis was performed using 
an unpaired or paired t test. Values of p < 0.05 were considered significant.
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6 CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
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In Chapter 1, I reviewed recent progress in the field of epithelial cell 
extrusion. While apical extrusion normally promotes cell death during homeostasis, 
I discussed how misregulation of apical extrusion and elevated survival signals 
might enable basally extruded cells to invade the underlying tissues. This review 
allowed me to speculate about how basal cell extrusion may relate to other 
known models for cell invasion: epithelial to mesenchymal transition (EMT), and 
collective or single cell invasion 1. Following this review covering the rationale for 
my thesis project, in Chapter 2, I presented work on the cytoskeletal mechanism 
I found to be critical for controlling the direction a cell extrudes. In this work, I 
showed that microtubules target P115 RhoGEF to control basolateral contraction 
of actin/myosin at the interphase between extruding and neighboring cells that is 
necessary for driving apical extrusion. Blocking this mechanism by microtubule 
disrupters causes cells to instead contract apically and extrude basally 2. This work 
led to a study showing that oncogenic mutation of Adenomatous Polyposis Coli 
also misregulates microtubules to drive extrusion basally 3. Given this knowledge, 
I next asked whether cells expressing other oncogenic mutations could also alter 
extrusion. In Chapter 3, I found that high levels of autophagy in cells expressing 
oncogenic K-Ras disrupts the normal S1P-S1P2 signaling required for apical 
extrusion. In addition, blocking autophagy with different chemical inhibitors 
or genetically is sufficient to rescue S1P localization and apical extrusion 4. An 
essential part of training to become an independent scientist involves collaborating 
with other investigators. Chapter 4 highlighted my collaboration with Yapeng Gu, 
a postdoc in the Rosenblatt lab. In this work, we found that extrusion-deficient 
epithelia lacking S1P2 form cell masses that are refractory to chemotherapy. Poor 
chemotherapy response derives from prolonged attachment of cells to the matrix 
and its associated survival signaling, which can be reversed by inhibiting Focal 
Adhesion Kinase (FAK). 
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While my graduate work provided answers to many of the questions that 
existed at the time I joined the lab, important questions still remain: What is the 
fate of live extruded cells in vivo? Is basal extrusion of cells expressing oncogenic 
K-Ras sufficient to invade the stroma?  We are developing several tools to answer 
these questions in vivo using the zebrafish animal model. Here, I will highlight the 
tools we are developing and summarize our ongoing studies while suggesting 
future studies that could teach us how misregulated cell extrusion could promote 
cancer cell invasion.
Our finding that cells expressing oncogenic K-Ras can extrude basally into 
the matrix, survive, and proliferate when grown in a 3-dimensional system in vitro 4 
made us wonder if cells expressing this mutation could invade in vivo. To address 
this, I developed a method to express K-Ras in the epidermis of the transparent 
zebrafish where cell extrusion and migration can be followed live without invasive 
techniques 5. The developing zebrafish epidermis is very similar in structure and 
cell type composition to the epithelium coating mammalian organs such as lung, 
prostate, and breast 6, 7. During development, zebrafish epidermis is a epithelial 
bilayer comprised of a basal p63 positive-layer of progenitor cells 8 and an outer 
cytokeratin 4 positive-layer 9, 10. Because we can readily film cells extruding and 
invading live by studying zebrafish epidermis, we believe that the knowledge we 
gain from these studies will serve as an excellent model to understand if basal 
extrusion can drive invasion in carcinomas. Additionally, zebrafish will allow us to 
rapidly test and screen for small molecules that block basal extrusion and target 
invasive cells to die.
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5.1 Expression of Oncogenic K-Ras in the Developing 
Zebrafish Epidermis
To test if extrusion of cells expressing oncogenic K-Ras is sufficient to 
enable invasion into the tissue underlying the epidermis of zebrafish, I expressed 
oncogenic EGFP-K-Ras (K-RasV12) or wild type EYFP-K-Ras (K-RasWT) in the 
developing outer cytokeratin positive layer. To do this, we used the Tol2 system 
11 to drive human K-RAS (V12 or WT) with a zebrafish cytokeratin 4 promoter. 
Injection of either DNA plasmid into one-cell stage wild type embryos drives mosaic 
expression of either K-Ras isoform.  I then follow the fate of the GFP-labeled cells 
once they become expressed at 12 hours by either time-lapse microscopy or by 
immunostaining.  I find that embryos expressing GFP-K-RasV12 form cell masses 
containing live and dying cells throughout the whole epidermis covering the body 
by 24 hpf (Figure 5.1).
5.2 Do Cells Expressing K-RasV12 Extrude from the Developing 
Zebrafish Epidermis?
Because EGFP-K-Ras is membrane bound, we can readily view the cell 
cortex to detect cell extrusion by contracting rosettes before the cell extrudes out. 
Alternatively, we can detect actin ring formation by co-injecting mRNA an F-actin 
binding protein (RFP-UtrCH) that encodes red fluorescent protein fused to the 
calponin homology domain of utrophin 5.
I find that while cells expressing K-RasWT are stationary in the epidermis, 
those expressing K-RasV12 basally extrude (Figure 5.2). Most of these basally 
extruded cells die shortly following extrusion, suggesting that K-RasV12 alone is 
not sufficient for cell survival. To test if a small percentage of K-RasV12 cells can 
survive after extrusion, we are currently working with the Cell Imaging Core Facility 
to film all the extrusion events in numerous embryos with high resolution. Typically, 
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however, transformation by a single oncogene results in cell death and oncogenic 
transformation requires collaborating mutations 12-15. Therefore, I am currently (in 
the next section) testing if other mutations cooperate with K-RasV12 to promote their 
survival following basal extrusion. 
5.3 Is Invasion and Survival of K-RasV12 Cells Enhanced 
by Loss of p53?
Because K-RasV12 expressing cells basally extruded from the epidermis but 
then died, I decided to test if other collaborating mutations could enable extruded 
cells to live. Lung and pancreatic cancers typically contain mutations that activate 
K-Ras and disrupt the tumor suppressor p53 16-18. When I injected K-Ras constructs 
in a p53 mutant fish or in wild type fish co-injected with p53 morpholino, each 24 
hpf embryo survived better than wild type fish and contained higher numbers of 
K-RasV12 positive cells and larger and more cell masses per embryo. Furthermore, 
while some K-RasV12 cells still die, some can be seen migrating below the periderm 
and within blood vessels (Figure 5.3). I am currently developing ways to film more 
embryos simultaneously using the Nikon A1R confocal microscope at the core 
facility, which enables fast and high resolution imaging to capture more events 
and be able to follow all cell movements from the beginning of extrusion to later 
migration. While visualizing EGFP-K-RasV12 cells in the vasculature suggests that 
these cells may be intravasating after they basally extrude, it is important to note 
that they may be able to enter before the blood vessels have formed, a process 
that ends at approximately 24hpf. To prevent extrusion until after blood vessels 
form so we can test how far these cells may transit, I will drive KRAS after 24 hpf in 
specific epithelial cell types after blood vessels formation. Additionally, these GFP-
positive cells may result from clearance by inflammatory macrophages, which 
more readily migrate to and engulf oncogenic cells 19. To investigate this possibility, 
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I will test if GFP positive cells within the vasculature are corpses of transformed 
cells, assessing if neutrophils and macrophages are associated with K-Ras cells 
and if these K-Ras cells are dead with apoptotic markers.  
5.4 Developing Tools to Spatially and Temporally Control 
K-Ras Expression 
We have characterized several GAL4 enhancer trap lines expressed in 
different epithelial cell types of the developing zebrafish (Eisenhoffer, G., Slattum, 
G., et al., in preparation & Otsuna, H., et al., under revision). To drive K-Ras 
in different epidermal cells using the Gal4-UAS system, I generated a UAS-K-
Ras human line. We tested these constructs in transient transgenesis assay by 
injecting UAS:EGFP-K-RASV12 or UAS:EYFP-K-RASWT plasmid DNA without Tol2 
transposase mRNA in one-cell stage periderm Et(zc1044:Gal4);Tg(UAS:nfs-
B-mCherry) embryos (hereafter called Periderm-Gal4). In preliminary results, I 
find the phenotypes from these embryos phenocopy those driven from the Krt4 
promoter: K-RasV12 cells extrude basally from the epidermis and form cells masses.
To delay the onset of K-Ras expression in the developing periderm, I 
am taking two approaches: 1) testing an antisense photo-cleavable morpholino 
against GAL4 (gal4-AS-photo-MO), which is destroyed by UV exposure, and 2) 
using an antisense morpholino against human K-RasV12 (K-RasV12-MO) to delay 
its expression. I have preliminary results showing that co-injecting 0.2 mM gal4-
AS-photo-MO and 25 pg UAS:KRASV12 followed by 1-minute exposure to 365nm 
wavelength at 24 hpf enables the control of EGFP-K-RasV12 expression in the 
Periderm-Gal4-mCherry line. Without photo-activation, 70% of the embryos co-
injected with gal4-AS-photo-MO and UAS:KRASV12 showed no expression of 
mCherry or EGFP fluorescence at 24hpf. However, in 2-day-old photo-activated 
embryos (24 hours after photoactivation), only 30% of embryos express mCherry 
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in the periderm in the tail and gill epithelium and GFP cells were undetectable. 
By day 5, EGFP-K-Ras cells start to appear in the epidermis. Because K-Ras 
expression occurs so slowly and at low frequency, I am further testing for the optimal 
concentrations of AS-photo-morpholinos and time to photoactivate; however, there 
is some concern that by 5dpf, much of the original plasmid will have degraded. To 
circumvent this problem, I am trying to stabilize the DNA expression by co-injecting 
with Tol2 transposase mRNA to promote DNA integration.
While trouble-shooting this method, I am currently trying to delay KRAS 
expression in the periderm by co-injecting with a K-RASV12-AS-morpholino, which 
should become diluted or degraded over time. I find that EGFP-K-RAS becomes 
expressed within the first 3 days of development.  In a pilot study, injected wild 
type or Periderm-Gal4 embryos with K-RASV12-AS-MO alone had no detectable 
phenotypes. When I co-inject this morpholino with CK- or UAS-driven K-RasV12 
constructs, 90% of injected embryos undergo normal development for the first 
two days but express EGFP positive cells through out the periderm and form cells 
masses by 4 dpf. These recent data are very compelling and suggest that we 
will now be able to quickly test if driving KRAS expression later in development 
after vasculature is fully formed still allows basally extruded cells to invade the 
underlying stroma and intravasate into blood vessels.
5.5 Future Perspectives to Spatially and Temporally Control 
K-Ras Expression
New techniques are being developed to generate inducible systems that 
precisely control the timing of transgene expression both in space and time 20. One 
approach, the ERT2-Gal4 system, where Gal4 expression can be driven reversibly 
by 4-OHT addition could be useful for our studies. Because it uses Gal4, these 
can also be crossed to effector UAS lines to drive genes of interest with temporal 
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control. ERT2-Gal4 has been successfully fused to tissue specific drivers to drive 
gene expression in the skin and a subset of migrating lateral line primordium with 
a Claudin B tight junction protein promoter 21. We may use reported Keratin 5 or 
4 similarly to express K-Ras in the skin epithelia 22 23. Importantly, these lines can 
be crossed to our already developed UAS-bearing transgenic lines and constructs 
that includes reporters or filamentous actin.
5.6 Expressing K-Ras in Other Cell Types
Cells expressing KRasV12 even with p53 loss may become trapped between 
two epithelial layers following basal extrusion. Therefore, we would like to drive 
KRasV12 in other cells within the epidermis where they may be more likely to invade 
from, such as ionocytes or basal cells. To this end, I have injected the UAS:EGFP-
K-RASV12 in a Gal4 enhancer trap line marking ionocytes (Eisenhoffer, G., Slattum, 
G., et al., in preparation). The ionocytes are imbedded between the two layers of 
the epidermis and are equivalent to Clara cells of the lung. Interestingly, some 
lung tumors are thought to originate from Clara cells 24 and their transformation 
with K-RAS may make these cells more invasive that differentiated superficial 
epidermal cells.  Similarly, I will express KRasV12 in a p63 basal progenitor line, as 
they may have more survival and proliferative potential than the periderm cells. 
5.7 Can Small Molecule Inhibitors Selectively Target K-Ras 
Expressing Cell to Extrude and Die?
Because we found that disrupting autophagy in K-RasV12 cells either 
chemically or genetically rescued S1P accumulation and apical extrusion 4, I will 
test if autophagy inhibitors can reverse invasion. Once I better establish if basal 
extrusion drives invasion, in collaboration with Adam Gardner, another student in 
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the lab, I will test if chloroquine, an autophagy inhibitor currently in clinical trials for 
tumors driven by oncogenic K-Ras, can target K-Ras expressing cells to apically 
extrude and die in vivo. Importantly, we will be able to also monitor the toxicity of 
surrounding wild type cells. Similarly, we will test other small molecules such as FAK 
inhibitors and other drugs alone or in combination with traditional chemotherapies 
to test their ability to reverse invasion or to target invasive cells to die. These 
experiments will help us develop novel therapies for tumors that have shown poor 
response to standard chemotherapies.
In this dissertation, I have presented work identifying novel insights into 
the mechanisms that govern epithelial cell extrusion both under physiological 
and pathological conditions. Additionally, I discussed the rationale for continuing 
our studies addressing other ways extrusion may become misregulated. So far, 
all the oncogenic mutations we have examined alter the direction of extrusion, 
suggesting basal extrusion may provide a conserved mechanism for tumor cells 
to initiate invasion. 
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Figure 5.1. Expressing oncogenic K-Ras in the developing zebrafish 
epidermis results in the formation of cell masses. (A) 24hpf wild type embryo 
un-injected (top),  Injected with CK-EYFP-K-RasWT  (middle) or CK:EGFP-K-RasV12 
(bottom) showing positive fluorescent cells (white arrows) and cell masses (white arrow 
head) trough out the epidermis. (B) Confocal projections of a fixed and stained cell 
mass showing EGFP-K-RasV12 positive cells (red arrows). (C) Quantification of cell 
masses in injected embryos where n= 209 embryos for K-RasV12 and 187 embryos 



























































Figure 5.2. Expression of CK:EGFP-K-RasV12 causes cells to extrude basally.
(A) Confocal projection and XZ cross-sections (below) of an early basal extrusion, 
whereas E-Cadherin (red), K-Ras (green), DNA (blue). (B) Stills from a movie 
showing that K-RasWT expressing cells are stationary in the epidermis (top), but 










Figure 5.3. Loss of p53 enhanced survival and Invasion of CK:EGFP-K-
RasV12 cells. (A) K-RasV12 cells (green) expressed in a p53 mutant fish survived 
better and contained higher numbers cells at 24hpf.  (B) Stills from a movie showing 
that CK:EGFP-K-RasV12 coinjected with a p53 morpholino appears to migrate 
from the top and basal layer of the epidermis whereas (red) is Tg line marking the 
zebrafish periderm. (C) Stills from a movie showing GFP positive cells (arrows) 
traveling and being cleared out from the circulatory system of a 48 hpf p53 mutant 
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